丹酚酸A通过DUSP介导ERK/JNK通路对大鼠心肌缺血/再灌注损伤抗凋亡作用及机制
|
摘要
目的：
本研究通过建立大鼠离体缺血/再灌注(ischemia/reperfusion, I/R)心脏和心肌细胞模型,以心肌梗死面积、心脏血流动力学变化、心肌坏死标记物、单个心肌细胞的收缩功能、凋亡相关蛋白、双特异性蛋白磷酸酶(Dual specificity protein phosphatase, DUSP)2/4/16以及ERK1/2和JNK通路上相关蛋白的表达变化为指标,观察丹酚酸A (Salvianolic acid A, SAA)对离体I/R心脏和心肌细胞收缩功能的恢复及凋亡的影响。探讨SAA对I/R损伤的保护作用及其可能的分子机制,从而为临床治疗心肌I/R损伤提供一种新的药物及治疗靶点。
方法：
1.清洁级成年雄性wistar大鼠,体重200-250g,分为正常对照组(CON, n=6), I/R组(I/R, n=6), SAA预处理组(SAA+I/R, n=6), ERK1/2抑制剂PD098059+I/R组(PD+I/R), ERK1/2抑制剂PD098059+SAA+I/R组(PD+SAA+I/R), JNK抑制剂SP600125+I/R组(SP+I/R)。应用离体心脏连接Langendorff装置,采用停灌、复灌方法模拟I/R过程,观察SAA(20μM)对离体I/R心脏的保护作用。CON组离体心脏持续用K-H液灌流200min; I/R组离体心脏持续灌流50min后,再缺血30min复灌120min; SAA+I/R组离体心脏持续灌流30min,进行SAA预处理20min后再缺血30min复灌120min; PD+I/R组PD预处理30min,余处理同I/R组；PD+SAA+I/R组进行SAA预处理前用PD预处理30min,余处理同SAA+I/R组；SP+I/R组SP预处理30min,余处理同I/R组。灌注过程中将一连接于压力传感器的充水水囊经肺静脉口进入左心房,经二尖瓣插入左室,以进入左室后LVEDP为5-15mmHg为充水水囊充水后标准,通过生物信号采集器测量心功能各项指标。分别于缺血前、再灌注30min、120min记录心率(HR)、左心室收缩压(LVSP).左心室舒张末压(LVEDP).左心室压变化最大速率(±dp/dtmax)。同时各组在再灌注15min时留取冠脉流出液待测乳酸脱氢酶(LDH)。再灌注结束后,冷冻心脏,TTC染色法测量各组心脏的心肌梗死面积。
2.以常规酶解法分离成年大鼠心肌细胞,采用缺糖缺氧、复糖复氧的方法模拟I/R过程,观察SAA对离体I/R心肌细胞的保护作用。所得心肌细胞,分为以下各组：(1)CON组：心肌细胞正常培养18h；(2)I/R组：心肌细胞正常培养13h后,培养基更换为模拟缺血液,放入三气培养箱中进行缺氧培养3h,然后将细胞培养基更换为高糖DMEM培养基,放入C02培养箱复糖复氧模拟再灌注；(3)SAA不同浓度组+I/R组：心肌细胞正常培养1h后,加入不同浓度SAA (1,5,10,15μM)预处理12h,再进行I/R,应用心肌细胞杆状率评价细胞的存活率,根据细胞的存活率确定SAA的最佳浓度,后述实验中SAA剂量均采用最佳浓度一种剂量进行；(4) PD+SAA+I/R组：进行SAA预处理前用PD预处理1h,余处理同SAA+I/R组；(5) SP+I/R组：SP预处理1h,余处理同I/R组。再灌注时间根据不同指标分为2h或6h。处理细胞分别进行以下实验：在异丙肾上腺素刺激(isoproterenol, ISO)状态下,收缩幅度用单个心肌细胞检测技术测定；用TUNEL及DAPI法检测心肌细胞凋亡率；用免疫印迹法(Western blot)测定Bcl-2、Bax、c-Jun氨基末端激酶(c-Jun N-terminal kinases, JNK),磷酸化-JNK (p-JNK),细胞外调节蛋白激酶(extracellular regulated protein kinases, ERK1/2),磷酸化-ERK1/2(p-ERK1/2)及DUSP2, DUSP4, DUSP16蛋白表达变化。
结果：
1.在离体I/R心脏水平上,与CON组相比,I/R能够明显地降低心功能的各种参数(P<0.01),增加LDH释放量,心肌梗死面积及心肌细胞凋亡率(P<0.01)；与I/R组相比,SAA+I/R, SP+I/R组,PD+SAA+I/R组,均可改善心功能的各种参数,降低LDH释放量,心肌梗死面积及心肌细胞凋亡率(P<0.05-0.01),而PD+I/R组与I/R组相比,心功能的各种参数,LDH的释放量,心肌梗死面积及心肌细胞凋亡率未见明显变化(P>0.05)；各组与PD+I/R组相比,结果等同于与I/R组相比；与SAA+I/R组比较,PD+SAA+I/R组心功能参数降低,LDH释放量,心肌梗死面积及心肌细胞凋亡率均有所增加(P<0.05),而SP+I/R组与SAA+I/R组比较,心功能参数,LDH释放量,心肌梗死面积及心肌细胞凋亡率未示明显差异(P>0.05)；而与PD+SAA+I/R组相比,SP+I/R组心功能参数升高,LDH释放量,心肌梗死面积及心肌细胞凋亡率减少明显(P<0.01)。由于PD+I/R组与单存I/R组相比,心脏血流动力学指标,心肌损伤标记物LDH,以及心肌细胞凋亡率三组未见明显变化,故在心肌细胞水平中,未进一步行PD+I/R组的相关试验。
2.在细胞水平上,与CON组相比,I/R后,单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平明显下降,p-JNK、Bax及DUSP2蛋白表达水平明显增加(P<0.05-0.01)；用SAA预处理后,能够增加单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平,降低p-JNK、Bax及DUSP2蛋白表达水平(P<0.05)；与I/R组比较,SAA+I/R, SP+I/R组,PD+SAA+I/R组,均可增加单个心肌细胞收缩幅度、p-ERK1/2、 Bcl-21及DUSP4/16蛋白表达水平,降低p-JNK、Bax及DUSP2蛋白表达水平(P<0.05)；相对于SAA+I/R组,PD+SAA+I/R组单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平降低,p-JNK、Bax及DUSP2蛋白表达水平上调(P<0.05)；而SP+I/R组与SAA+I/R组比较,单个心肌细胞收缩幅度、p-ERK1/2、p-JNK、Bcl-2、Bax、DUSP2及DUSP4/16蛋白表达水平均未见明显变化(P>0.05)；与PD+SAA+I/R组相比,SP+I/R组增加了单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平,降低了p-JNK、Bax及DUSP2蛋白表达水平(P<0.05)。
结论：
JNK可以通过DUSP2抑制ERK1/2的激活,而ERK1/2则可以通过DUSP4/16去磷酸化抑制了JNK的活性；SAA可能通过抑制DUSP2介导的JNK通路激活ERK1/2通路以及通过激活DUSP4/16介导的ERK1/2通路抑制JNK通路激活,从而发挥对缺血/再灌注心肌细胞抗凋亡的作用。
Objective:
The purpose of this study is to establish an rat ischemia/reperfusion (I/R) heart and cardiomyocyte model, and to observe the effects of Salvianolic acid A (SAA) pretreatment on the I/R myocardium in vitro and cardiomyocyte contraction function and apoptosis with these indexes for myocardium infarction area, cardiac hemodynamics, myocardium necrosis markers, single cardiomyocytes contractile function, apoptosis related proteins, dual specificity protein phosphatase (DUSP)2/4/16and ERK1/2/JNK pathways related protein expression. Meanwhile, the cardioprotection against I/R injury and underlying molecular mechanisms are able to be discussed, thus a kind of new drugs and therapeutic targets can be provides for clinical treatment of myocardium I/R.
Methods:
1. Clean grade adult male Wistar rats, weight220-260g, were divided into normal control group (CON group, n=6), I/R group (I/R, n=6), SAA pretreatment group (SAA+I/R, n=6), ERK1/2inhibitors PD098059+I/R group (PD+I/R), ERK1/2inhibitors PD098059+SAA+I/R group (PD+SAA+I/R), JNK inhibitors SP600125+I/R group (SP+I/R). The cardioprotection of SAA (20μM) on I/R heart in vitro was observed by application of Langendorff heart connection device in vitro and I/R process was simulated by stopping perfusion following reperfusion. The heart in vitro in CON group was continuously perfused K-H solution perfusion for160min; the heart in vitro in I/R group was perfused for10min, then ischemia for30min following reperfusion for120min; In SAA+I/R group, the heart in vitro was perfused for10min, then SAA pretreatment for20min, ischemia for30min following reperfusion for120min; In PD+I/R group, the heart in vitro was perfused for10min, then PD pretreatment for20min, the following procedure was the same as I/R group; In PD+SAA+I/R group, PD was pretreated for30min, the following process was the same as SAA+I/R group; In SP+SP group, SP was pretreated for20min, the following procedure was the same as I/R group; During the course of reperfusion, A filling water sac connecting pressure sensor was inserted into left ventricle via pulmonary vein orifice, left atrium, and mitral valve, the filling water sac was located in LVEDP for5-15mmHg. heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP) and maximum rate of left ventricular pressure (+dp/dtmax) were recorded for30min prior to I/R and120min after I/R. At the same time, lactate dehydrogenase (LDH) from coronary effluent for reperfusion15min was assayed. After reperfusion, heart was frozen, myocardial infarction areas were measured by TTC staining method.
Adult rat cardiomyocytes were isolated in conventional enzymolysis approach, then I/R process was simulated by lacking of oxygen, sugar following recovering sugar, oxygen to observe cardioprotection of SAA for I/R cardiomyocytes in vitro.
In cells level, there were five groups.(1) CON group:cardiomyocytes were cultivated for18h;(2) I/R group:cardiomyocytes were cultivated for13h, then were placed in three gas incubator for3h, next, cardiomyocyt es were cultured in high glucose DMEM medium and CO2incubator to simulate reperfusion.(3) SAA+I/R group:cardiomyocytes were cultivated for1h, then I/R was performed after different concentrations of SAA (1,5,10,15^M) pretreatment for12h. The optimal concentration of SAA was determined according to cell survival rate by observing the rod rate of cardiomyocytes and then was performed in following experiments.(4) PD+SAA+I/R group:PD was added for1h prior to SAA pretreatment, then the following process was as the same as SAA+I/R group;(5) SP+I/R group:pretreatment with SP for1h, I/R was performed. The contraction amplitude of cardiomyocytes was determined with a single detection technology by isopropyl adrenaline stimulating; Cardiomyocytes apoptosis was detected by TUNEL and DAPI; The protein expression levels for Bcl-2, Bax, JNK, phosphorylation-JNK (p-JNK), ERK1/2, phosphorylation-ERK1/2(p-ERK1/2), DUSP2/4/16were assayed by Western blot.
Results:
1. In cardiac I/R level in vitro, compared with CON group, various parameters of heart function were reduced significantly(P<0.01) and LDH release, area of myocardial infarction, cell apoptosis were increased significantly following I/R (P<0.01); Compared with I/R group, various parameters of heart function were improved significantly ((P<0.05)) and LDH release, area of myocardial infarction, cell apoptosis were reduced significantly among SAA+I/R group, SP+I/R group, PD+SAA+I/R group (P＜0.01); The results, PD+I/R compared with different groups, were as the same as I/R group; In PD+SAA+I/R group, heart function parameters were reduced and LDH release, area of myocardial infarction, cell apoptosis rate were increased (P<0.05) by comparsion with SAA+I/R group; However, SP+I/R group compared with SAA+I/R group, the indexes mentioned above were not significant different (P>0.05); Compared with PD+SAA+I/R group, various parameters of heart function were elevated significantly (P＜0.05)) and LDH release, area of myocardial infarction, cell apoptosis were reduced significantly in SP+I/R group (P＜0.01). With regard to the values of hemodynamic indicators, LDH and apoptosis rate between PD+I/R group and I/R group were not statistically different (P>0.05), so the related test in PD+I/R group was not performed at cell level.
2. At cellular level, compared with CON group, contraction amplitude of single cardiomyocyte, protein expression level for p-ERK1/2, Bcl-2and DUSP4/16were decreased significantly(P<0.01), however, p-JNK, Bax and DUSP2protein expressions were increased significantly (P＜0.05-0.01) following I/R; With SAA pretreatment, contraction amplitude of single cardiomyocyte. protein expression level for p-ERK1/2, Bcl-2, DUSP4/16were increased and p-JNK, Bax, DUSP2protein levels were reduced significantly (P＜0.05); Compared with I/R group, contraction amplitude of single cardiomyocyte, protein expression level for p-ERK1/2, Bcl-2, DUSP4/16were increased significantly and p-JNK, Bax, DUSP2protein expressions were reduced significantly (P＜0.05) among SAA+I/R group, SP+I/R group, PD+SAA+I/R group (P<0.01); In PD+SAA+I/R group, contraction amplitude of single cardiomyocyte, protein expression level for p-ERK1/2, Bcl-2, DUSP4/16were reduced significantly and p-JNK, Bax, DUSP2protein expressions were activated significantly (P<0.05) by comparsion with SAA+I/R group; However, SP+I/R group compared with SAA+I/R group, the indexes mentioned above were not significant different (P>0.05); Compared with PD+SAA+I/R group, the protein expression levels for p-ERK1/2, Bcl-2, DUSP4/16and single cardiomyocyte contraction amplitude were increased significantly and p-JNK, Bax, DUSP2protein levels were lowered in SP+I/R group (P<0.05).
Conclusion:
During the course of I/R, JNK pathway can inhibit the ERK1/2activation via DUSP2and ERK1/2inhibit ERK1/2activation via DUSP4/16.
SAA can inhibit DUSP2-mediated JNK pathway for activation of ERK1/2and activate DUSP4/16-mediated ERK1/2by JNK dephosphorylation to play anti-apoptosis role in I/R cardiomyocytes.
本研究通过建立大鼠离体缺血/再灌注(ischemia/reperfusion, I/R)心脏和心肌细胞模型,以心肌梗死面积、心脏血流动力学变化、心肌坏死标记物、单个心肌细胞的收缩功能、凋亡相关蛋白、双特异性蛋白磷酸酶(Dual specificity protein phosphatase, DUSP)2/4/16以及ERK1/2和JNK通路上相关蛋白的表达变化为指标,观察丹酚酸A (Salvianolic acid A, SAA)对离体I/R心脏和心肌细胞收缩功能的恢复及凋亡的影响。探讨SAA对I/R损伤的保护作用及其可能的分子机制,从而为临床治疗心肌I/R损伤提供一种新的药物及治疗靶点。
方法：
1.清洁级成年雄性wistar大鼠,体重200-250g,分为正常对照组(CON, n=6), I/R组(I/R, n=6), SAA预处理组(SAA+I/R, n=6), ERK1/2抑制剂PD098059+I/R组(PD+I/R), ERK1/2抑制剂PD098059+SAA+I/R组(PD+SAA+I/R), JNK抑制剂SP600125+I/R组(SP+I/R)。应用离体心脏连接Langendorff装置,采用停灌、复灌方法模拟I/R过程,观察SAA(20μM)对离体I/R心脏的保护作用。CON组离体心脏持续用K-H液灌流200min; I/R组离体心脏持续灌流50min后,再缺血30min复灌120min; SAA+I/R组离体心脏持续灌流30min,进行SAA预处理20min后再缺血30min复灌120min; PD+I/R组PD预处理30min,余处理同I/R组；PD+SAA+I/R组进行SAA预处理前用PD预处理30min,余处理同SAA+I/R组；SP+I/R组SP预处理30min,余处理同I/R组。灌注过程中将一连接于压力传感器的充水水囊经肺静脉口进入左心房,经二尖瓣插入左室,以进入左室后LVEDP为5-15mmHg为充水水囊充水后标准,通过生物信号采集器测量心功能各项指标。分别于缺血前、再灌注30min、120min记录心率(HR)、左心室收缩压(LVSP).左心室舒张末压(LVEDP).左心室压变化最大速率(±dp/dtmax)。同时各组在再灌注15min时留取冠脉流出液待测乳酸脱氢酶(LDH)。再灌注结束后,冷冻心脏,TTC染色法测量各组心脏的心肌梗死面积。
2.以常规酶解法分离成年大鼠心肌细胞,采用缺糖缺氧、复糖复氧的方法模拟I/R过程,观察SAA对离体I/R心肌细胞的保护作用。所得心肌细胞,分为以下各组：(1)CON组：心肌细胞正常培养18h；(2)I/R组：心肌细胞正常培养13h后,培养基更换为模拟缺血液,放入三气培养箱中进行缺氧培养3h,然后将细胞培养基更换为高糖DMEM培养基,放入C02培养箱复糖复氧模拟再灌注；(3)SAA不同浓度组+I/R组：心肌细胞正常培养1h后,加入不同浓度SAA (1,5,10,15μM)预处理12h,再进行I/R,应用心肌细胞杆状率评价细胞的存活率,根据细胞的存活率确定SAA的最佳浓度,后述实验中SAA剂量均采用最佳浓度一种剂量进行；(4) PD+SAA+I/R组：进行SAA预处理前用PD预处理1h,余处理同SAA+I/R组；(5) SP+I/R组：SP预处理1h,余处理同I/R组。再灌注时间根据不同指标分为2h或6h。处理细胞分别进行以下实验：在异丙肾上腺素刺激(isoproterenol, ISO)状态下,收缩幅度用单个心肌细胞检测技术测定；用TUNEL及DAPI法检测心肌细胞凋亡率；用免疫印迹法(Western blot)测定Bcl-2、Bax、c-Jun氨基末端激酶(c-Jun N-terminal kinases, JNK),磷酸化-JNK (p-JNK),细胞外调节蛋白激酶(extracellular regulated protein kinases, ERK1/2),磷酸化-ERK1/2(p-ERK1/2)及DUSP2, DUSP4, DUSP16蛋白表达变化。
结果：
1.在离体I/R心脏水平上,与CON组相比,I/R能够明显地降低心功能的各种参数(P<0.01),增加LDH释放量,心肌梗死面积及心肌细胞凋亡率(P<0.01)；与I/R组相比,SAA+I/R, SP+I/R组,PD+SAA+I/R组,均可改善心功能的各种参数,降低LDH释放量,心肌梗死面积及心肌细胞凋亡率(P<0.05-0.01),而PD+I/R组与I/R组相比,心功能的各种参数,LDH的释放量,心肌梗死面积及心肌细胞凋亡率未见明显变化(P>0.05)；各组与PD+I/R组相比,结果等同于与I/R组相比；与SAA+I/R组比较,PD+SAA+I/R组心功能参数降低,LDH释放量,心肌梗死面积及心肌细胞凋亡率均有所增加(P<0.05),而SP+I/R组与SAA+I/R组比较,心功能参数,LDH释放量,心肌梗死面积及心肌细胞凋亡率未示明显差异(P>0.05)；而与PD+SAA+I/R组相比,SP+I/R组心功能参数升高,LDH释放量,心肌梗死面积及心肌细胞凋亡率减少明显(P<0.01)。由于PD+I/R组与单存I/R组相比,心脏血流动力学指标,心肌损伤标记物LDH,以及心肌细胞凋亡率三组未见明显变化,故在心肌细胞水平中,未进一步行PD+I/R组的相关试验。
2.在细胞水平上,与CON组相比,I/R后,单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平明显下降,p-JNK、Bax及DUSP2蛋白表达水平明显增加(P<0.05-0.01)；用SAA预处理后,能够增加单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平,降低p-JNK、Bax及DUSP2蛋白表达水平(P<0.05)；与I/R组比较,SAA+I/R, SP+I/R组,PD+SAA+I/R组,均可增加单个心肌细胞收缩幅度、p-ERK1/2、 Bcl-21及DUSP4/16蛋白表达水平,降低p-JNK、Bax及DUSP2蛋白表达水平(P<0.05)；相对于SAA+I/R组,PD+SAA+I/R组单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平降低,p-JNK、Bax及DUSP2蛋白表达水平上调(P<0.05)；而SP+I/R组与SAA+I/R组比较,单个心肌细胞收缩幅度、p-ERK1/2、p-JNK、Bcl-2、Bax、DUSP2及DUSP4/16蛋白表达水平均未见明显变化(P>0.05)；与PD+SAA+I/R组相比,SP+I/R组增加了单个心肌细胞收缩幅度、p-ERK1/2、Bcl-2及DUSP4/16蛋白表达水平,降低了p-JNK、Bax及DUSP2蛋白表达水平(P<0.05)。
结论：
JNK可以通过DUSP2抑制ERK1/2的激活,而ERK1/2则可以通过DUSP4/16去磷酸化抑制了JNK的活性；SAA可能通过抑制DUSP2介导的JNK通路激活ERK1/2通路以及通过激活DUSP4/16介导的ERK1/2通路抑制JNK通路激活,从而发挥对缺血/再灌注心肌细胞抗凋亡的作用。
Objective:
The purpose of this study is to establish an rat ischemia/reperfusion (I/R) heart and cardiomyocyte model, and to observe the effects of Salvianolic acid A (SAA) pretreatment on the I/R myocardium in vitro and cardiomyocyte contraction function and apoptosis with these indexes for myocardium infarction area, cardiac hemodynamics, myocardium necrosis markers, single cardiomyocytes contractile function, apoptosis related proteins, dual specificity protein phosphatase (DUSP)2/4/16and ERK1/2/JNK pathways related protein expression. Meanwhile, the cardioprotection against I/R injury and underlying molecular mechanisms are able to be discussed, thus a kind of new drugs and therapeutic targets can be provides for clinical treatment of myocardium I/R.
Methods:
1. Clean grade adult male Wistar rats, weight220-260g, were divided into normal control group (CON group, n=6), I/R group (I/R, n=6), SAA pretreatment group (SAA+I/R, n=6), ERK1/2inhibitors PD098059+I/R group (PD+I/R), ERK1/2inhibitors PD098059+SAA+I/R group (PD+SAA+I/R), JNK inhibitors SP600125+I/R group (SP+I/R). The cardioprotection of SAA (20μM) on I/R heart in vitro was observed by application of Langendorff heart connection device in vitro and I/R process was simulated by stopping perfusion following reperfusion. The heart in vitro in CON group was continuously perfused K-H solution perfusion for160min; the heart in vitro in I/R group was perfused for10min, then ischemia for30min following reperfusion for120min; In SAA+I/R group, the heart in vitro was perfused for10min, then SAA pretreatment for20min, ischemia for30min following reperfusion for120min; In PD+I/R group, the heart in vitro was perfused for10min, then PD pretreatment for20min, the following procedure was the same as I/R group; In PD+SAA+I/R group, PD was pretreated for30min, the following process was the same as SAA+I/R group; In SP+SP group, SP was pretreated for20min, the following procedure was the same as I/R group; During the course of reperfusion, A filling water sac connecting pressure sensor was inserted into left ventricle via pulmonary vein orifice, left atrium, and mitral valve, the filling water sac was located in LVEDP for5-15mmHg. heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP) and maximum rate of left ventricular pressure (+dp/dtmax) were recorded for30min prior to I/R and120min after I/R. At the same time, lactate dehydrogenase (LDH) from coronary effluent for reperfusion15min was assayed. After reperfusion, heart was frozen, myocardial infarction areas were measured by TTC staining method.
Adult rat cardiomyocytes were isolated in conventional enzymolysis approach, then I/R process was simulated by lacking of oxygen, sugar following recovering sugar, oxygen to observe cardioprotection of SAA for I/R cardiomyocytes in vitro.
In cells level, there were five groups.(1) CON group:cardiomyocytes were cultivated for18h;(2) I/R group:cardiomyocytes were cultivated for13h, then were placed in three gas incubator for3h, next, cardiomyocyt es were cultured in high glucose DMEM medium and CO2incubator to simulate reperfusion.(3) SAA+I/R group:cardiomyocytes were cultivated for1h, then I/R was performed after different concentrations of SAA (1,5,10,15^M) pretreatment for12h. The optimal concentration of SAA was determined according to cell survival rate by observing the rod rate of cardiomyocytes and then was performed in following experiments.(4) PD+SAA+I/R group:PD was added for1h prior to SAA pretreatment, then the following process was as the same as SAA+I/R group;(5) SP+I/R group:pretreatment with SP for1h, I/R was performed. The contraction amplitude of cardiomyocytes was determined with a single detection technology by isopropyl adrenaline stimulating; Cardiomyocytes apoptosis was detected by TUNEL and DAPI; The protein expression levels for Bcl-2, Bax, JNK, phosphorylation-JNK (p-JNK), ERK1/2, phosphorylation-ERK1/2(p-ERK1/2), DUSP2/4/16were assayed by Western blot.
Results:
1. In cardiac I/R level in vitro, compared with CON group, various parameters of heart function were reduced significantly(P<0.01) and LDH release, area of myocardial infarction, cell apoptosis were increased significantly following I/R (P<0.01); Compared with I/R group, various parameters of heart function were improved significantly ((P<0.05)) and LDH release, area of myocardial infarction, cell apoptosis were reduced significantly among SAA+I/R group, SP+I/R group, PD+SAA+I/R group (P＜0.01); The results, PD+I/R compared with different groups, were as the same as I/R group; In PD+SAA+I/R group, heart function parameters were reduced and LDH release, area of myocardial infarction, cell apoptosis rate were increased (P<0.05) by comparsion with SAA+I/R group; However, SP+I/R group compared with SAA+I/R group, the indexes mentioned above were not significant different (P>0.05); Compared with PD+SAA+I/R group, various parameters of heart function were elevated significantly (P＜0.05)) and LDH release, area of myocardial infarction, cell apoptosis were reduced significantly in SP+I/R group (P＜0.01). With regard to the values of hemodynamic indicators, LDH and apoptosis rate between PD+I/R group and I/R group were not statistically different (P>0.05), so the related test in PD+I/R group was not performed at cell level.
2. At cellular level, compared with CON group, contraction amplitude of single cardiomyocyte, protein expression level for p-ERK1/2, Bcl-2and DUSP4/16were decreased significantly(P<0.01), however, p-JNK, Bax and DUSP2protein expressions were increased significantly (P＜0.05-0.01) following I/R; With SAA pretreatment, contraction amplitude of single cardiomyocyte. protein expression level for p-ERK1/2, Bcl-2, DUSP4/16were increased and p-JNK, Bax, DUSP2protein levels were reduced significantly (P＜0.05); Compared with I/R group, contraction amplitude of single cardiomyocyte, protein expression level for p-ERK1/2, Bcl-2, DUSP4/16were increased significantly and p-JNK, Bax, DUSP2protein expressions were reduced significantly (P＜0.05) among SAA+I/R group, SP+I/R group, PD+SAA+I/R group (P<0.01); In PD+SAA+I/R group, contraction amplitude of single cardiomyocyte, protein expression level for p-ERK1/2, Bcl-2, DUSP4/16were reduced significantly and p-JNK, Bax, DUSP2protein expressions were activated significantly (P<0.05) by comparsion with SAA+I/R group; However, SP+I/R group compared with SAA+I/R group, the indexes mentioned above were not significant different (P>0.05); Compared with PD+SAA+I/R group, the protein expression levels for p-ERK1/2, Bcl-2, DUSP4/16and single cardiomyocyte contraction amplitude were increased significantly and p-JNK, Bax, DUSP2protein levels were lowered in SP+I/R group (P<0.05).
Conclusion:
During the course of I/R, JNK pathway can inhibit the ERK1/2activation via DUSP2and ERK1/2inhibit ERK1/2activation via DUSP4/16.
SAA can inhibit DUSP2-mediated JNK pathway for activation of ERK1/2and activate DUSP4/16-mediated ERK1/2by JNK dephosphorylation to play anti-apoptosis role in I/R cardiomyocytes.
引文
[1]Satoh N, Kitada Y. Cardioprotective effect of MCC-135 is associated with inhibition of Ca2+ overload in ischemic/reperfused hearts [J]. Eur J Pharmacol,2004,499(1-2):179-187.
[2]Eefting FR, Wigman J, Pannekoek WJ. et al. Role of apoptosis in reperfusion injury[J]. Cardiovase Res, 2004,61(3):414-426.
[3]Yue TL, Bao W, Gu JL, et al. Rosiglitazone Treatment in Zucker Diabetic Fatty Rats Is Associated With Ameliorated Cardiac Insulin Resistance and Protection From Ischemia/Reperfusion-Induced Myocardial Injury[J]. Diabetes,2005,54(2):554-562.
[4]] Lee MG, Jeong MH, Ahn Y, et al. Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes[J]. Korean Circ J,2009,39(6):243-250.
[5]Zhang L, Zhang W, Zhao Y, Yang X, Fang L, Wang S, Shi L, Yu X, Wang S, Yang H, Sun J, Tian S, Du G.. Research progress of salvianolic acid A[J]. Zhong guo Zhong Yao Za Zhi,2011,36(19):2603-2609. (Article in Chinese)
[6]Huaying Fan, Liu Yang, Fenghua Fu, et al. Cardioprotective Effects of Salvianolic Acid A on Myocardial Ischemia-Reperfusion Injury In Vivo and In Vitro [J]. J Bio Medicl Science,2011,18(3):30.
[7]Jiang B, Wu W, Li M, et al. Cardioprotection and matrix metalloproteinase-9 regulation of salvianolic acidson myocardial infarction in rats[J]. Planta Med,2009,75(12):1286-92.
[8]Fan H, Yang L, Fu F, et al. Cardioprotective effects of salvianolic Acid a on myocardial ischemia-reperfusion injury in vivo and in vitro [J]. Evid Based Complement Alternat Med,2012,2012: 508938.
[9]Wang B, Liu JX, Meng HX, et al. Blocking effect of salvianolic acid a on calcium channels in isolated rat ventricular myocytes [J]. Chin J Integr Med,2012,18(5):366-70.
[10]Wang SB, Yang XY, Tian S, et al. Effect of salvianolic acid A on vascular reactivity of streptozotocin-induced diabetic rats [J]. Life Sci,2009,85(13-14):499-504.
[11]Du GH, Qiu Y, Zhang JT. Protective effect of salvianolic acid a on ischemia-reperfusion induced injury in isolated rat heart[J].Yao Xue Xue Bao,1995,30(10):731-735.
[12]Wang XJ, Wang ZB, Xu JX. Effect of salvianic acid A on lipid peroxidation and membrane permeability in mitochondria [J]. J Ethno pharmacol,2005,97(3):441-445.
[13]Wang SB, Tian S, Yang F, et al. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats [J]. Eur J Pharmacol,2009,15(1-3):125-132.
[14]Jiang B, Zhang L, Li M, et al. Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress [J]. Food Chem Toxicol,2008,46(5):1510-1515.
[15]Pan H, Li D, Fang F. et al. Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury [J]. J Cardiovase Pharmacol.2011.58(5):535-542.
[16]Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart:angels versus demons in a heart-breaking tale [J]. Physiol Rev,2010,90(4):1507-1546.
[17]Adamek A, Jung S, Dienesch C, et al. Role of 5-lipoxyge-nase in myocardial ischemia-reperfusion injury in mice [J]. Eur J Pharmacol,2007,571(1):51-54.
[18]Tao J, Zhu W, Li Y, et al. Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion [J]. Am J Physiol Heart Circ Physiol,2011,301(4):H1471-1486.
[19]Xu H, Yao Y, Su Z, et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-& alpha;/JNK[J]. Am J Physiol Heart Circ Physiol,2011, 300(3):H913-921.
[20]Zhai CL, Zhang MQ, Zhang Y, et al. Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway[J]. Acta Pharmacol Sin,2012, 33(12):1477-1487.
[21]Matsui T, Tao J, Monte F, et al. Role of apoptosis in cardiovascular disease[J]. Apoptosis,2009,14(5): 536-548.
[22]Hajjar, RJ. Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation,2001,104(7):330-335.
[23]Li C, Tian J, Li G, et al. Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways. Eur. J. Pharmacol,2010,649(6):100-107.
[24]Sun D, Huang J, Zhang Z, et-al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One,2012,7(6):334-341.
[25]Qi, L, Pan H, Li, D, et al. Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes. Eur. J. Pharmacol.2011,668(1-2):201-207.
[26]Ferrandi C, Ballerio R, Gaillard CR, et al. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in an aesthetized rats. Br J Pharmacol, 2004,142(6):953-960.
[27]Strohm C, Barancik T, Bruhl M.L, et al. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium[J]. J Cardiovasc Pharmacol,2000,36,218-229.
[28]Cheng, HY. Hsieh MT. Neuroprotective effect of luteolin on amyloid beta protein (25-35)-induced toxicity in cultured rat cortical neurons[J]. Phytother Res,2010,24(6):S102-S108.
[29]Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease[J]. Apoptosis,2009,14,536-548.
[30]Maenpaa CJ, Shames BD, Why SK, et al. Oxidant-mediated apoptosis in proximal tubular epithelial cells following ATP depletion and recovery. Free Radic Biol Med,2008,44,518-526.
[31]Nam YJ, Mani K, Ashton A, et al. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell 2004,15,901-912.
[32]Song J, Liu K, Yi J. Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium/mitochondrion/caspases-dependent pathway. Planta Med,2010,76,433-438.
[33]Negoro S, Kunisada K, Tone E, et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res.2000,47,797-805.
[34]Bohlooly YM, Olsson B, Bruder CE, et al. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes, 2011,54(1):51-62.
[35]Tsang MW, Davidoff R, Korach A, et al. Diastolic dysfunction after coronary artery bypass grafting the effect of glucose-insulin-potassium infusion.J Card Surg,2012,22(3):185-91.
[36]Boengler K, Hilfiker-Kleiner D, Drexler H, et al.The myocardial JAK/STAT pathway:From protection to failure. Pharmacol Ther,2008,120,172-185.
[37]Miura K, Fujibuchi W, Unno M. Splice variants in apoptotic pathway. Exp Oncol.2012,34(3):212-7.
[38]Murrry CE, Jenning RB, Reimar KA, et al. Preconditioning with ischemia:adelayoflethalcell injury in ischemic myocardium[J]. Circulation,1986,74(5):1124
[39]Saraste A, Arola A, Vuorinen T, et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol.2010,12(5):255-62.
[39]Wagner M, Siddiqui MA. Signaling networks regulating cardiac myocyte survival and death[J]. Curr Opin Investig Drugs,2009,10,928-937.
[40]Shirato K, Imaizumi K, Miyazawa K, et al. Apoptosis induction preceded by mitochondrial depolarization in multiple myeloma cell line U266 by 2-aminophenoxazine-3-one. Biol Pharm Bull,2011,31(1):62-7.
[41]Burley DS, Ferdinandy P, Baxter GF. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion:Opportunities and obstacles for survival signaling Br J Pharmacol,2007,152, 855-869.
[42]Han J, Kim N, Joo H, et al. ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol,2002,283, H1545-1554.
[43]Guanetal P, Linz W, Hubschle T, et al. Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies. J Transl Med,2013,11(1):84.
[44]Hu C, Chen J, Dandapat A, et al. LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J. Mol. Cell. Cardiol,2008,44(7):76-83.
[45]Kataoka K, Hasegawa K, Sawamura T, et al. LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun,2003,300(4):656-660.
[46]Lv L, Zhang Y, Kong Q. Luteolin prevents LPS-induced TNF-a expression in cardiac myocytes through inhibiting NF-κB signaling pathway. Inflammation,2011,34(5):620-629.
[47]Miura T, Liu Y, Goto M, et al. Mitochondrial ATP-sensitive K+ channels play a role in cardioprotection by Na+-H+ exchange inhibition against ischemia/reperfusion injury. J. Am. Coll. Cardiol,2001,37(7): 957-963.
[48]Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion [J]. Am Heart J,2000, 139(2n3):S115-S119.
[49]Bohlooly YM, Bollano E, Mobini R, et al. Selective cerebral. expression of growth hormone alters cardiacfunction, morphology, energy metabolism and catecholamines in trans genicmice[J]. Growth HomrIGF Res,2005,15(2):148-155.
[50]Apstein C. Increased glycolytie substrate protection improves ischemic cardiac dysfunction and reduces injury[J]. Am Heart J,2000,139(2Pt3):S107-S114.
[51]Nordlie MA, Wold LE, Simkhovich BZ, et al. Molecular aspects of Ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy[J]. J Cardio vase Pharmacol Ther,2006,11(1):17-30.
[52]Galang N, Sasaki H, Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy[J]. Toxicology,2000,148(2/3):111-118.
[53]Kim JK, Pedram A, Razandi M, et al. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinaseis[J]. J Biol Chem,2006,281(10): 6760-6767.
[54]Castedo E, Segovia J, Escudero C, et al. Ischemia-reperfusion injury duirng experimental heart transplantation:evlauation of trimetaz idinepscytoprotective effect [J]. Rev Esp Cordial,2005,58(8): 941-950.
[55]Claeysetal DM, Forgiarini LF, da Rosa DP. Endobronchial perfluorocarbon administration decreases lung injury in an experimental model of ischemia and reperfusion. J Surg Res,2013, doi:pii: S0022-4804(13)00061-9.10.1016/j.jss.2013.01.035.
[56]Maenpaa CJ, Shames BD, Vanwhy SK, et al. Oxidant mediated-apoptosis in proximla tubular epithelial cells following ATP depletion and recovery [J]. Free Radical Biol Med,2008,44(4):518-526.
[57]Feygin J, Hu Q, Swingen C, et al. Relationships between regional Myocardial wall stress and bioenergetics in heart with left ventricular hypertrophy [J]. Am J Physiol Hear Circ Physiol,2008,294 (5): 2313-2321.
[58]Kandzair DE. Double negatives[J]. Am Hean J,2003,145(1):9-11.
[59]Brunner F, Maier R, Andrew P, et al. Attenuation of myocardial ischemia/reperfusion in mice with myocyte speciifc overexpression of endothelial nitric oxidesynthase [J], Cardio vase Res,2003,57 (1): 55-62.
[60]Kwon KY, Cho CH, Kim SP, et al. Apoptosis induced by preservation and reperfusion in canine lung transplantation[J]. Transplant Proc,2003,35(1):134-137.
[61]Maulik N, Yoshida T, Engelman RM, et al. Ischemic preconditioning attenuates apoptotic cell death associated with isehemia/reperfusion[J]. Mol Cell Bio chem,1998,186(1/2):139-145.
[62]SarasteA. Apoptosis in humna acute myocardial infarction[J]. Circulation,1997,95(2):320-323.
[63]Shiirto K, Otani H, Yamamoto F, et al. MK2 2 gene knockout mouse hearts carry anti-apoptotic signal and resistant to ischemia reperfusion injury [J]. J Mol Cell Cardiaol,2005,38(1):93-97.
[64]Venardos KM, Zatta AJ, Marshall T, et al. Reduced L-arginine transport contributes to the pathogenesis of myocardial isehemia-repefusion injury [J]. J Cell Bio chem.,2009,108(1):156-168.
[65]Adamek A, Jung S, Dienesch C, et al. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice [J]. Eur J Pharmacol,2007,571(1):51-54.
[66]Xie JR, Yu LN. Cardioprotcetive effects of eyelosporine. A inaninvivo model for mycoardial ischemia and reperfusion[J]. Acta Anaesthesiol Scand,2007,51(7):909-913.
[67]韩景波,张以昆,方显明.论治冠心病的经验[J].国际中医中药杂志,2011,15(4)：156-158.
[68]陈相.浅谈心肌缺血再灌注损伤的中医病机及其防治[J].陕西中医,2008,29(6)：697-699.
[69]邓铁涛,康文英,沃兴德等.血府逐瘀汤对乳鼠心肌细胞缺血再灌注损伤的影响[J].中国药物与临床.2006,6(8)：590-592.
[70]赵文举,赵彩云.冠心病不稳定心绞痛病案再讨论：兼与张东等大夫商榷[J].中医杂志,1998,9：553-554.
[71]张文高,黄先勇.心肌心肌缺血预处理机理研究近况[J].中国急救医学,2002,22(3)：177.
[72]杨培君,高承贤,楼兰花等.杨培君治疗冠心病心绞痛经验[J].中医杂志,2004,10(7)：737-738.
[73]倪欢欢.林钟香治疗心血管病验案3则[J].江西中医药,2012,3：23-25.
[74]文小敏,袁晓清,贺运河.益气活血方对急性心肌梗死气虚血瘀型治疗作用的临床研究[J].南方医科大学学报,2008,1：149-150.
[75]杨大成,武宗义,侯彬等.心络胶囊在不稳定型心绞痛患者介入治疗中的作用[J].中国医药导报,2010,20:17-20.
[76]方居正.不活动时胸痛应防心绞痛[J].老年健康,2007,12(2)：110-113.
[77]方旭.心血管病经方论治[M].北京：人民卫生出版社,2007.
[78]孙文奇,杨关林.杨关林教授中西医结合治疗冠心病经验[J].吉林中医药杂志,2008,12：46-48.
[79]冯玲,曹洪欣,曹洪欣.益气升陷法治疗心血管疾病经验[J].中医杂志,2009,4：302-303
[80]王万军,胡焕柱,马长春.温阳化瘀法论治冠心病心绞痛30例[J].吉林中医药杂志,2007,5：21.
[81]刘欣,杨引,刘新.参附注射液预处理对大鼠心肌缺血再灌注损伤时心肌能量代谢的影响[J].中国中医急诊,2009,18(7)：1117-1118.
[82]沈映君.中药药理学[M].人民卫生出版社,2004年,3月.
[83]赵燕,件文,侯京武,等.钙超负荷和丹酮对线粒体过氧化的影响.生物化学与生物物理学报,1995,27(6)：610-615.
[84]石刚刚,尹俊,陈绍如,等.丹参和血液稀释对心肌缺血/再灌注损伤的保护作用.中国中西医结合杂志,1999,19(1)：40-42.
[85]藤木辛一.丹参酮关联化合物的研究.国外医学中医学分册,1991,13(4)：53-55.
[86]陈铎葆.红花提取物预处理对缺血再灌注心肌的影响[J].中医杂志,‘2006,47(2)：652-654.
[87]夏泉.当归的药理作用研究进展[J].时珍国医国药,2012,3(15)：1112-113.
[88]欧阳昌汉,吴基良,陈金和.黄芩苷对大鼠心肌缺血再灌注时细胞凋亡的影响[J].中药药理与临床.2011,22(2)：19-21.
[89]雷正一,王硕仁.黄芪对心血管系统的作用.中国中西医杂志,2003,13(7)：443.
[90]石刚刚,陈锦香,李长潮,等.黄芪注射液对冠状动脉直接作用的研究.中药新药与临床药理,2010,10(1)：38-39.
[91]陈健.黄芪注射液的药理作用及临床应用.天津医科大学学报,2005,11(1)：153-157
[92]周苏宁,马学盛,张文高.黄芪注射液防治心血管疾病的临床和基础研究.中国中西医结合急救杂志,2010,7(3)：124-125
[93]冯津萍,卢奕,赵炳让.黄芪抑制家兔心肌缺血/再灌注时细胞凋亡的实验研究.中国中西医结合急救杂志,2001,8(1)：13-15
[94]王丽娟.麦冬药理作用与临床应用研究进展[J].中华医学研究杂志,2009,5(9)：23-25.
[95]林巧.赤芍药理作用与临床应用的研究进展[J].中华医学研究杂志,2009,6(5)：34-36..
[96]赵惠,李益民.刺五加注射液对冠心病心绞痛的的LPO、SOD变化的影响.新中医,1996,62-65.
[97]Kerry NL, Abbey M.Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro [J] Atherosclerosis,1997,135(1):93-102.
[98]LekaNSs J, Rallidis LS, Anareadou I, et al. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart isease [J]. Eur J Cardiovasc Prev and Rehabil,2005,12(6): 596-600.
[99]赵文晓.白黎芦醇对冠脉结扎诱发大鼠急性心肌缺血的保护作用的研究.J HARBIN MEDICAL UNIVERSITY.2006,40(3):69.
[100]Dernek S, INSzler M, Erkasap N, et al. Cardioprotection with resveratrol pretreamtent:improved beneficial effects over standard treatment in rat hearts after global ischemia [J]. Scand Cardiovasc J,2004,38(4): 245-254.
[101]张志琳,吴鸿飞,包仕尧,等.血管内皮细胞缺氧性损伤及药物干预作用的实验观察.江西医药,2012,24(11)：805.
[102]林蓉,刘俊田,甘伟杰,等.川芎嗪对缺氧缺糖状态下培养的血管内皮细胞EVC-304的影响.中国中药杂志,2004,29(5)：462-464.
[103]朱陵群,赵明镜,王硕仁,等.血府逐瘀121服液对大鼠缺氧一再给氧损伤心脏微血管内皮细胞黏附分子表达的影响[J].中西医结合心脑血管病杂志,2011,4(8)：692-694.
[104]陈铎葆.红花提取物预处理对缺血再灌注心肌的影响[J].中医杂志,2006,47(2)：652-654.
[105]吴永涛,罗毅,顾云,等.参附注射液对大鼠心肌缺血再灌注损伤的保护作用[J].中国比较医学杂志,2011,17(1)：26-29.
[106]马晓鹂,张良清,邵义明,等.参附注射液对缺血再灌注损伤大鼠心肌细胞凋亡和NF-KB表达的影响[J].中国医师杂志,2011,9(6)：759-760.
[107]沈炳权,蔡兆斌,徐群红,等.葛根素对家兔心肌缺血再灌注损伤的保护作用[J].中国中西医结合急救杂志,2009,11(6)：361-363.
[108]吕宝经,荣烨之.生脉散对急性心肌梗塞患者的抗脂质过氧化作用.中国中西医结合杂志,2012,14(12)：712-715.
[109]何涛,张红星,高清元.生脉注射液在心脏直视手术中对心肌缺血/再灌注损伤的保护作用.临床医药实践杂志,2005,14(1)：28-29.
[110]张殿清,王漪绮,关承华,等.复方丹参与辅酶心肌线粒体Q10琥珀酸脱氢酶活性的影响.哈尔滨医科大学学报,1991,25(6)：413-414.
[111]苏晓华,梁殿权,王孝鸣,等.丹参素(DS-182)对心肌线粒体氧自由基损伤的保护作用.中国病理生理杂志,1992,8(2)：122-124.
[112]贾钰华,周玉平,孙学刚,等.定心方防治心肌缺血再灌注心律失常大鼠的心肌蛋白质组初步研究[J].辽宁中医杂志,21307,34(9)：1212--1214.
[113]吴伟康,侯灿,罗汉川等.四逆汤改善缺血心肌能量代谢的作用及机制探讨.中国病理生理杂志,1998,14(6)：634-636.
[114]吴健宇,李仪奎,符胜光,等.补阳还五汤药物血清对自由基损伤的血管内皮细胞的保护作用：中药药理与临床,2009,15(2)：3-5.
[115]储胜利,施学筠,席时芳,等.黄芪皂甙提高心脏保存效果的实验研究[J].中国中西医结合杂志,2011,19(8)：481-483.
[116]徐贵成,高荣林,吴以岭,等.通心络胶囊治疗冠心病心绞痛的临床研究[J].中国中西医结合杂志,2012,7(2)：231-233.
[117]张华,梁慕筠,马志雄,等.补阳还五汤治疗冠心病的临床研究及其作用机制探讨[J].中国中西医结合杂志,12005,15(4)：213-215.
[118]Morrison LE, Whittaker RJ, Klepper RE, et al. Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model [J]. Am J Physiol Heart Circ Physiol,2004,286(3):H847-855.
[119]Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts:focus on Akt and protein kinase C signaling [J]. J Pharmacol Exp Ther,2005,315(3): 1125-1135.
[120]Fang F, Li D, Pan H, et al. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion[J]. Pharmacology,2011,88(3-4): 149-158.
[121]Qarawani D, Cohen A, Nahir M, et al. Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan[J]. Int J Cardiol,2012, S0167-5273(12):1194-1121.
[122]Kapur A, Qureshi AC, Gallagher S, et al. Myocardial function may improve equally in diabetic patients following both multivessel percutaneous coronary intervention and coronary artery bypass grafting: results from a CARDia trial substudy [J]. Eur J Echocardiogr,2011,12(12):904-909.
[123]Arbel Y, Banai S. Response to the letter:How to manage coronary slow flow following PCI [J]. Int J Cardiol,2012,154(3):373.
[124]Mrdovic I, Savic L, Krljanac G, et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention:insight into the RISK-PCI trial [J]. Coron Artery Dis,2012,23(1):1-8.
[125]Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury:a neglected therapeutic target. J Clin Invest,2013,123(1):92-100.
[126]Lishmanov YB, Maslov LN. Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use [J]. Kardiologiia,2010,50(6):68-74
[127]陈丽娜,王化良.瓜蒌薤白半夏汤治疗胸痹研究进展[J].河南中医,2012,9：1254-1256.
[128]潘明政.以活血化瘀为主辨证论治消渴胸痹症[J].中国全科医学：医生读者版,2010,2：55-56.
[129]Baines CP. How and when do myocytes die during ischemia and reperfusion:the late phase [J]. J Cardiovasc Pharmacol Ther,2011,16(3-4):239-243.
[130]Xu J, Tian W, Ma X, et al. The molecular mechanism underlying morphine-induced Akt activation:roles of protein phosphatases and reactive oxygen species [J]. Cell Biochem Biophys,2011,61(2):303-311.
[131]Penna C, Alloatti G, Gallo MP, et al. Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart [J]. Cell Mol Neurobiol,2010,30(8):1171-1179.
[132]Geelen T, Paulis LE, Coolen BF, et al. Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury[J]. Contrast Media Mol Imaging,2013,8(2):117-126.
[133]Heusch G. Cardioprotection:chances and challenges of its translation to the clinic [J]. Lancet,2013, 381(9861):166-175.
[134]Ren JY, Song JX, Lu MY, et al. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats:Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P [J]. Regul Pept,2011,169(1-3):49-57.
[135]He H, Xu J, Xu Y, et al.Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats [J]. J Ethnopharmacol, 2012,140(1):73-82.
[136]Wu Q, Li H, Wu Y, et al. Protective effects of muscone on ischemia-reperfusion injury in cardiacmyocytes [J]. J Ethnopharmacol,2011,138(1):34-39.
[137]Zhou L, Zuo Z, Chow MS. Danshen:an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use [J]. J Clin Pharmacol,2005,45(12):1345-1359.
[138]Tao YY, Liu CH. Progress of research on mechanism of salvia miltiorrhiza and its chemical ingredients against liver fibrosis[J]. Zhong Xi Yi Jie He Xue Bao,2004,2(2):145-148.
[139]Zhang L, Zhang W, Zhao Y, et al. Research progress of salvianolic acid A [J]. Zhongguo Zhong Yao Za Zhi,2011,36(19):2603-2609.
[140]Li L. Protective effects of schisanhenol, salvianolic acid A and SY-L on oxidative stress induced injuries of cerebral cells and their mechanisms [J]. Sheng Li Ke Xue Jin Zhan,1998,29(1):35-38.
[141]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury [J]. Molecules,2011,16(12):10002-10012.
[142]Qin Y, Yu Y, Dong H, et al. MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis [J]. Int J Med Sci,2012,9(6): 413-423.
[143]Sun Q, Kang Z, Cai J, et al. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats [J]. Exp Biol Med,2009,234(10):1212-1219.
[144]Gomes OM, Magalhaes Mde M, Abrantes RD. Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts [J]. Rev Bras Cir Cardiovasc,2010,25(3): 388-392.
[145]Strasen J, Ritter O. Role of nNOS in cardiac ischemia-reperfusion injury[J]. Trends Cardiovasc Med, 2011,21(2):58-63.
[146]Vilahur G, Juan-Babot O, Pena E, et al. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction [J]. J Mol Cell Cardiol,2011,50(3):522-533.
[147]Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats[J]. PLoS One,2012,7(11):e48872.
[148]Janssen PM. Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere [J]. Am J Physiol Heart Circ Physiol,2010,299(4):H 1092-1099.
[149]Andersen JL, Kornbluth S. The tangled circuitry of metabolism and apoptosis[J]. Mol Cell,2013, 49(3):399-410.
[150]Bonneau B, Prudent J, Popgeorgiev N,et al. Non-apoptotic roles of Bcl-2 family:The calcium connection [J]. Biochim Biophys Acta,2013 Jan 27. doi:pii:S0167-4889(13) 00036-0.10.1016/ j.bbamcr.2013.01.021.
[151]Tsuruyama T, Okamoto S, Fujimoto Y, et al. Histology of intestinal allografts:lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis [J]. Am J Surg Pathol.2013,37(2):178-184.
[152]Distefano G, Sciacca P. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure[J]. Ital J Pediatr,2012,38(5):41.
[153]Yin XL, Shen H, Zhang W, et al.Inhibition of endoplasm reticulum stress by anisodamine protects against myocardial injury after cardiac arrest and resuscitation in rats [J]. Am J Chin Med,2011, 39(5):853-866.
[154]Tao Z, Zhao Z, Lee CC.5'-Adenosine monophosphate induced hypothermia reduces early stage myocardial ischemia/reperfusion injury in a mouse model [J]. Am J Transl Res,2011,3(4):351-361.
[155]Verma YK, Raghav PK, Raj HG, et al. Enhanced heterodimerization of Bax by Bcl-2 mutants improves irradiated cell survival [J]. Apoptosis,2013,18(2):212-225.
[156]Zhang L, Zhang S. Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells [J]. Phytother Res,2011,25(10):1551-1557.
[157]Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease [J]. Apoptosis,2009,14(4):536-48.
[158]Shaw J, Kirshenbaum LA. Molecular regulation of autophagy and apoptosis during ischemic and non-ischemic cardiomyopathy[J]. Autophagy,2008,4(4):427-434.
[159]Hu ZY, Liu J. Effects of emulsified isoflurane on haemodynamics and cardiomyocyte apoptosis in rats with myocardial ischaemia[J]. Clin Exp Pharmacol Physiol,2009,36(8):776-83.
[160]Bo CJ, Chen B, Jia RP, et al. Effects of ischemic preconditioning in the late phase on homing of endothelial progenitor cells in renal ischemia/reperfusion injury [J]. Transplant Proc,2013,45(2):511-6.
[161]Chablais F, Veit J, Rainer G, et al. The zebrafish heart regenerates after cryoinjury-induced myocardial infarction [J]. BMC Dev Biol,2011,11(4):21-25.
[162]Yu SJ, Yoon JH, Yang JI, et al. Enhancement of hexokinase Ⅱ inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition [J]. J Bioenerg Biomembr,2012,44(1):101-115.
[163]Kelly KJ, Kluve-Beckerman B, Zhang J, et al. Intravenous cell therapy for acute renal failure with serum amyloid A protein-reprogrammed cells [J]. Am J Physiol Renal Physiol,2010,299(2):F453-64.
[164]Wang X, Wang Y, Jiang M, et al. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways [J]. J Ethnopharmacol,2011, 135(3):662-671.
[165]Witzel F, Maddison L, Bluthgen N. How scaffolds shape MAPK signaling:what we know and opportunities for systems approaches [J]. Front Physiol,2012,3:475. doi:10.3389/fphys.2012.00475.
[166]Ismail NS, Pravda EA, Li D, et al. Angiopoietin-1 reduces H (2) O(2)-induced increases in reactive oxygen species and oxidative damage to skin cells [J]. Invest Dermatol,2010,130(5):1307-1317.
[167]Taj G, Agarwal P, Grant M, et al.MAPK machinery in plants:recognition and response to different stresses through multiple signal transduction pathways [J]. Plant Signal Behav,2010,5(11):1370-1378.
[168]Lin CL, Tseng HC, Chen RF, et al. Intracellular zinc release-activated ERK-dependent GSK-3β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury [J]. Cell Death Differ, 2011,18(10):1651-1663.
[169]Xu H, Yao Y, Su Z,et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-& alpha;/JNK [J].Am J Physiol Heart Circ Physiol, 2011,300(3):H913-921.
[170]Kurian MV, Hamilton L, Keeven J, et al. Enhanced cell survival and diminished apoptotic response to simulated ischemia-reperfusion in H9c2 cells by magnetic field preconditioning [J]. Apoptosis,2012, 17(11):1182-1196.
[171]Liu H, Pedram A, Kim JK.Oestrogen prevents cardiomyocyte apoptosis by suppressing p38a-mediated activation of p53 and by down-regulating p53 inhibition on p38β [J]. Cardiovasc Res,2011,89(1): 119-128.
[172]Hu X, Wang H, Liu J, et al. The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation [J]. Arch Dermatol Res,2013 Mar 15. [Epub ahead of print]
[173]Wiejak J, Dunlop J, Stoyle C,et al. The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun [J]. Cell Signal,2012,24(8):1690-1699.
[174]Wang X, Chen WR, Xing D. A pathway from JNK through decreased ERK and Akt activities for FOXO3 a nuclear translocation in response to UV irradiation [J]. J Cell Physiol,2012, 227(3):1168-1178.
[175]Ferrandi C, Ballerio R, Gaillard P, et al. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats [J]. Br J Pharmacol,2004,142(6):953-960.
[176]Ottani A, Giuliani D, Galantucci M,et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism [J]. Eur J Pharmacol,2010,637(1-3):124-130.
[177]Fey D, Croucher DR, Kolch W, et al. Crosstalk and signaling switches in mitogen-activated protein kinase cascades [J]. Front Physiol,2012,3:355. doi:10.3389/fphys.2012.00355.
[178]Masuda K, Katagiri C, Nomura M,et al. MKP-7, a JNK phosphatase, blocks ERK-dependent gene activation by anchoring phosphorylated ERK in the cytoplasm [J]. Biochem Biophys Res Commun, 2010,393(2):201-206.
[179]Krstic A, Kocic J, Ilic V, et al. Effects of IL-17 on erythroid progenitors growth:involvement of MAPKs and GATA transcription factors [J]. J Biol Regul Homeost Agents,2012,26(4):641-652.
[180]Bermudez O, Pages G, Gimond C. The dual-specificity MAP kinase phosphatases:critical roles in development and cancer [J]. Am J Physiol Cell Physiol.2010,299(2):C189-202.
[181]Keyse SM. Dual-specificity MAP kinase phosphatases (MKPs) and cancer[J]. Cancer Metastasis Rev. 2008,27(2):253-61.
[182]Wei X, Guo W, Wu S, et al. Oxidative stress in NSC-741909-induced apoptosis of cancer cells [J]. J Transl Med,2010,16,8:37.
[183]Katagiri C, Masuda K, Urano T, et al.Phosphorylation of Ser-446 determines stability of MKP-7[J]. J Biol Chem,2005,280(15):14716-14722.
[184]Paumelle R, Tulasne D, Leroy C,et al. Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells[J]. Mol Biol Cell,2000, 11(11):3751-3763.
[185]Monick MM, Powers LS, Gross TJ, et al. Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1[J]. J Immunol,2006,177(3):1636-45.
[186]Dickinson RJ, Keyse SM. Diverse physiological functions for dual-specificity MAP kinase phosphatases[J]. J Cell Sci,2006,119(Pt 22):4607-4615.
[187]Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival[J].FASEB J,2008,22(4):954-965.
[1]Blebea J, Kerr JC, Padberg FT, et al. Triphenyl tetrazolium chloride as a histochemical marker of skeletal muscle ischemia and reperfusion injury[J]. Curr surg,1987,44(2): 134-136
[2]Murry CE, Jennings RB. Reimer KA, et al. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardiumr[J]. Circulation,1986,74(5):11124-1136.
[3]Yoshitomi O, Cho S, Hara T, et al. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs.Shock,2012,38(1):92-97.
[4]Asdaq SM, Inamdar MN, Asad M. Pharmacodynamic interaction of garlic with propranolol in ischemia-reperfusion induced myocardial damage. Pak J Pharm Sci,2010,23(1):42-47.
[5]Li MP, Sun GJ, You XH. Effects of electroacu puncture stimulation of scalp-point on cardiac sympathetic discharges, myocardial betal-adrenoceptor protein expression and plasma norepinephrine concentration in myocardial ischemia-reperfusion injury rats. Zhen Ci Yan Jiu,2012,37(5):385-389.
[6]Wu WY, Wang YP. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol Sin,2012, 33(9):1119-1130.
[7]Pan H, Li D, Fang F, et al. Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. J Cardiovasc Pharmacol,2011, 58(5):535-542.
[8]Yue QX, Xie FB, Song XY, et al. Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury. J Ethnopharmacol,2012,141(2):659-667.
[9]Tang Y, Wang M, Chen C,et al. Cardiovascular protection with danshensu in spontaneously hypertensive rats. Biol Pharm Bull,2011,34(10):1596-1601.
[10]Han B, Zhang X, Zhang Q, et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis,2011, 104(5):313-324.
[11]Obal D, Dai S, Keith R, et al. Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Res Cardiol,2012,107(6):305.
[12]Bhandary B, Piao CS. Kim DS, et al. The protective effect of rutin against ischemia/reperfusion-associated hemodynamic alteration through antioxidant activity. Arch Pharm Res,2012.35(6):1091-1097.
[13]Sun WH, Liu F, Chen Y. et al. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem Biophys Res Commun,2012,421(2):164-169.
[14]Huang C, Li R, Zeng Q, et al. Effect of minocycline postconditioning and ischemic postconditioning on myocardial ischemia-reperfusion injury in atherosclerosis rabbits. J Hua zhong Univ Sci Technolog Med Sci,2012,32(4):524-529.
[15]徐正褂,王万铁,李东.川芎嗪对家兔心肌IRI的保护作用[J].基础医学与临床,1997,17(4)：68-71.
[16]Chen G, Fu Y, Wu X. Protective effect of Salvia miltiorrhiza extract against renal ischemia-reperfusion-induced injury in rats. Molecules,2012,17(2):1191-1202.
[17]Tang Y, Wang M, Le X, et al. Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats. Phytomedicine,2011, 18(12):1024-1030.
[18]Wang L, Lv D, Liang R, et al. Protection on myocardial ischemia and reperfusion injury by Salvia miltiorrhiza hairy root in isolated Langendorff rat hearts. Zhongguo Zhong Yao Za Zhi,2009,34(14):1848-1851.
[19]昊志,夏正远,黄海波等.复方丹参对心内直视手术心肌缺血再灌注后血清过氧化脂质及前列环素变化的影响[J].临床麻醉学杂志,2008,18(5)：242-244.
[20]Wu L, Qiao H, Li Y, et al. Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats. Phytomedicine,2007,14(10):652-658.
[21]Hu X, Xu C, Zhou X, et al.Sodium butyrate protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Biomed Pharmacother,2010,25(6):578-583.
[22]Fu J, Huang H, Liu J, et al. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol,2007,568(1-3):213-221.
[23]辛双生,王志宏,用俊英等.丹参液内关穴注射对心肌缺血性损伤大鼠心肌SOD、MDA含量与红细胞膜流动性关系的研究[J].中医研究,1999,12(2)：13-14.
[24]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules,2011,16(12):10002-12.
[25]Wang L, Lv D, Liang R, et al.Protection on myocardial ischemia and reperfusion injury by Salvia miltiorrhiza hairy root in isolated Langendorff rat hearts. Zhongguo Zhong Yao Za Zhi,2009,34(14):1848-1851.
[26]王泽君,鲍光宏.氧自由基引起心肌损伤的离子通道机制.高血压杂志,1998,1-4：237-240.
[27]Tanonaka K, Motegi K, Arino T, et al. Possible pathway of Na(+) flux into mitochondria in ischemic heart. Biol Pharm Bull,2012,35(10):1661-1668.
[28]Shintani-Ishida K, Inui M, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2□ overload. J Mol Cell Cardiol,2012,53(2):233-239.
[29]Jin C, Wu J, Watanabe M, et al. Mitochondrial K+ channels are involved in ischemic postconditioning in rat hearts. J Physiol Sci,2012,62(4):325-332.
[30].Chong ZZ, Xu QP, Sun JN. Effects and mechanisms of tri-acetylshikimic acid on platelet adhesion to neutrophils induced by thrombin and reperfusion after focal cerebral ischemis in rats[J]. Acta Pharmacol Sin,2001,22(8):679-684.
[31]Ialkel S, Ilekel H, Guger G, et al. Alterations in superoxide dismutase, glutathione penoxidase and catalase activities in experimental cerebral ischemia-reperfusion[J]. Res Exp Med,1999,199(3):167-176.
[32]Chiu PY, Wong SM, Leung HY, et al. Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKC□/mK (ATP) pathway in rats[J]. Phytomedicine,2011,18(11):916-925.
[33]Chiu PY, Wong SM, Leung HY, et al. Long-term treatment with danshen-gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive protein kinase C-ε/mK (ATP) pathway in rats[J]. Rejuvenation Res,2011,14(2):173-184.
[34]Beiral HJ, Rodrigues-Ferreira C, Fernandes AM, et al. The Impact of Stem Cells on Electron Fluxes, Proton Translocation and ATP Synthesis in Kidney Mitochondria after Ischemia/Reperfusion[J]. Cell Transplant,2012,23(4):123-126.
[35]Chiu PY, Wong SM, Leung HY, et al. Long-term treatment with danshen-gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive protein kinase C-ε/mK (ATP) pathway in rats[J]. Rejuvenation Res,2011,14(2):173-184.
[36]张桦,焦选茂,王孝铭等.缺血再灌注对大鼠心肌线粒体电子传递与质子泵出偶联的影响[J].中国病理生理杂志,1993,9(5)：561.
[37]Zhang WH, Wang JS, Zhou Y, et al. Gadolinium chloride and salvia miltiorrhiza compound ameliorate reperfusion injury in hepatocellular mitochondria[J]. World J Gastroenterol, 2003,9(9):2040-2044.
[38]胡敏霞,周密妹,胡先敏等.丹参酮对脑缺血再灌注大鼠脑损伤的保护作用及对能量代谢的影响[J].中国临床药学杂志,2006,15(3)：176-179.
[39]Chiu PY, Wong SM, Leung HY, et al. Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKC/mK (ATP) pathway in rats[J]. Phytomedicine,2011,18(11):916-925.
[40]De FI, Fernandez SM, Essenfeld SE, et al. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL in sepsis [J]. Chest,2004,125(6):1980-1982.
[41]Papathanassoglou ED, Moynihan JA, Ackerman M H. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patient? A review and a theoretical framework [J]. Crit Care Med,2010,28(2):537-549.
[42]Xie Z, Koyama T,Suzuki J, et al. Coronary reperfusion following ischemia:different expression of bcl2 and bax proteins and cardiomyocyte apoptosisr[J]. Jpn Heart J,2007.42: 759-770.
[43]Peng W, Liu Y, Xu WJ, et al. Role of beclin 1-dependent autophagy in cardioprotection of ischemic preconditioning[J]. J Huazhong Univ Sci Technolog Med Sci,2013,33(1):51-56.
[44]Shen M, Wu RX, Zhao L, et al. Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism[J]. PLoS One,2012,7(12):e51223.
[45]Dong L, Fan Y, Shao X, et al. Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis[J]. Food Chem Toxicol,2011,49(12):3211-3216.
[46]Yamamura T, Otani H, Nakao Y, et al. IGF21 differentailly regulates Bcl2 X1 and Bax and confers myocardial protection in the rat heartr[J]. Physiol Heart Circ Physiol,2011,280(4):1-12.
[47]Starczynski J, Pepper C, Pratt G, et al. The P2X7 receptor gene polymorphism has no effect on clinical prognostric markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytie leukaemia [J]. Br J Haenatol,2003, 123(1):66-71.
[48]张代富,阮长武,刘中民等.丹参对大鼠急性心肌缺血再灌注时心肌细胞凋亡及凋亡相关基因表达的影响[J].上海医学,2003,26(9)：1669-1670.
[49]Hin SW, Park JW, Suh MH, et al. Persistent expression of Fas/FasL mRNA in the mouse hippocampus after a single NMDA injection [J]. Neurochem,2008,71(6):1773-1776.
[50]Jiang CM, Han LP, Li HZ, et al. Calcium-sensing receptors induce apoptosis in cultured neonatal rat ventricular cardiomyocytes during simulated ischemia/reperfusion [J]. Cell Biol Int,2008,32(7):792-800.
[51]Lee P, Sata M, Lefer DJ, et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia reperfusion in vivor [J]. Am J Physiol Heart C/re Physiol,2003, 284(2):H456-H463.
[52]Pan H, Li D, Fang F, et al. Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury [J]. J Cardiovasc Pharmacol, 2011,58(5):535-542.
[53]Yin Y, Guan Y, Duan J, et al. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusioninjury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol,2013,699(1-3):219-26.
[54]Fan H, Yang L, Fu F, et al. Cardioprotective effects of salvianolic Acid a on myocardial ischemia-reperfusioninjury in vivo and in vitro. Evid Based Complement Alternat Med,2012,2012:508938. doi:10.1155/2012/508938. Epub 2011 Jun 25.
[55]Yang LM, Xiao YL, Ou Yang JH. Inhibition of magnesium lithospermate B on the c-Jun N-terminal kinase 3 mRNA expression in cardiomyocytes encountered ischemia/reperfusion injury. Yao Xue Xue Bao,2003,38(7):487-491.
[56]HICKEY MJ, Hu RLEY JV, MORRISON WA. temporal and spatial relationship between no-flew phenomenon and postischemic necrosis in skeletal muscle. Am J Physio1.1996, 271(2):1277-1286.
[57]Gao F, Sun G, Ren X, et al. Protective effect of salvianolic acid B on isolated heart ischemia/reperfusion injury in rats. Zhongguo Zhong Yao Za Zhi,2012,37(3):358-361.
[58]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules,2011,16(12): 10002-10012.
[59]王保和,傅伟,李竹庭.丹酚酸B对急性心肌缺血再灌注损伤大鼠心肌保护作用的机制研究[J].天津中医学院学报,2004,23(3)：132-133.
[60]胡利民,张艳军,王威等.冰片与丹酚酸B和三七总皂苷配伍对局灶性脑缺血再灌注大鼠脑VEGF mRNA表达的影响[J].中国中西医结合急救杂志,2005,12(5)：263-266.
[61]李祖纯,夏祯芸.丹参酮ⅡA磺酸钠注射液对急性心肌梗死再灌注治疗后左心功能的影响[J].2006,24(3)：87-89.
[62]Han B, Zhang X, Zhang Q, et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis,2011, 104(5):313-24.
[63]Koeppen M, Harter PN, Bonney S, et al. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology,2012,116(6):1245-1257.
[64]Thomas CJ, Ng DC, Patsikatheodorou N, et al.Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK. Eur J Pharmacol,2011, 658(2-3):160-167.
[65]Zhao LJ, Men XL, Kong XY, et al. Preventive effects of salvia miltiorrhiza on multiple organ edema in the rats of limb ischemia/reperfusion Zhongguo Ying Yong Sheng Li Xue Za Zhi.2012,28(3):281-283.
[66]Jin YC, Kim CW. Kim YM. et al. Cryptotanshinone. a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur J Pharmacol,2009, 614(1-3):91-97.
[67]Han X, Liu JX, Ma XB, et al. Effects of shuang shen tong guan (SSTG) on TNF-alpha, ICAM-1 during myocardial ischemia-reperfusion injury. Zhong guo Zhong Yao Za Zhi, 2004,29(11):1073-1075.
[68]Jiang KY, Kung CG, Gu ZC. Effects of tanshinone-A sulfonate on adhesion molecule expression of endothelial cells and platelets in vitro[J]. Acta Phamacologica Sinica,1998, 19(1):47-50.
[69]Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.Pharmacol Ther.2008,117(2):280-295.
[70]Oh KS, Oh BK, Mun J, et al. Salvianolic acid A suppress lipopolysaccharide-induced NF-κB signaling pathway by targeting IKKβ[J]. Int Immunopharmacol,2011, 11(11):1901-1906.
[71]Shintani-Ishida K, Inui M, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2+ overload[J]. J Mol Cell Cardiol,2012,53(2):233-239.
[72]He Z, Peng Z, Jin L, et al. Effect of morphine preconditioning on mitochondrial permeability transition pore after myocardial ischemia-reperfusion injury in rats [J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2010,35(8):800-806.
[73]Inui M, Shintani-Ishida K, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2+ overload[J]. J Mol Cell Cardiol,2011,23(3):245-249.
[74]Yu W, Wang JJ, Wen ZY, et al. Influences and mechanism of verapamil on ischemia/reperfusion injury in cardiomyocytes of streptozotocin-induced diabetes mellitus rats[J]. Zhonghua Yi Xue Za Zhi,2010,90(42):3003-3007.
[75]Barba I, Chavarria L, Ruiz-Meana M, et al. Effect of intracellular lipid droplets on cytosolic Ca2+ and cell death during ischaemia-reperfusion injury in cardiomyocytes[J]. J Physiol, 2009,587(Pt 6):1331-1341.
[76]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury [J]. Molecules,2011, 16(12):10002-10012.
[77]李玉梅,陈旭华.丹参对缺血心肌细胞L型钙电流的影响[J].安徽中医学院学报,2003,22(4)：29-32
[78]Dejonckheere E, Vandenbroucke RE, Libert C. Matrix metalloproteinases as drug targets in ischemia/reperfusion injury[J].Drug Discov Today,2011,16(17-18):762-778.
[79]高秀梅,张伯礼,商洪才等.复方丹参对缺血预适应大鼠心肌蛋白激酶C表达的影响.中 草药[J],2003,34(10)：933-935.
[80]Hu F, Koon CM, Chan JY, et al. The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury [J]. BMC Complement Altern Med,2012,12:249. doi:10.1186/1472-6882-12-249.
[2]Eefting FR, Wigman J, Pannekoek WJ. et al. Role of apoptosis in reperfusion injury[J]. Cardiovase Res, 2004,61(3):414-426.
[3]Yue TL, Bao W, Gu JL, et al. Rosiglitazone Treatment in Zucker Diabetic Fatty Rats Is Associated With Ameliorated Cardiac Insulin Resistance and Protection From Ischemia/Reperfusion-Induced Myocardial Injury[J]. Diabetes,2005,54(2):554-562.
[4]] Lee MG, Jeong MH, Ahn Y, et al. Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes[J]. Korean Circ J,2009,39(6):243-250.
[5]Zhang L, Zhang W, Zhao Y, Yang X, Fang L, Wang S, Shi L, Yu X, Wang S, Yang H, Sun J, Tian S, Du G.. Research progress of salvianolic acid A[J]. Zhong guo Zhong Yao Za Zhi,2011,36(19):2603-2609. (Article in Chinese)
[6]Huaying Fan, Liu Yang, Fenghua Fu, et al. Cardioprotective Effects of Salvianolic Acid A on Myocardial Ischemia-Reperfusion Injury In Vivo and In Vitro [J]. J Bio Medicl Science,2011,18(3):30.
[7]Jiang B, Wu W, Li M, et al. Cardioprotection and matrix metalloproteinase-9 regulation of salvianolic acidson myocardial infarction in rats[J]. Planta Med,2009,75(12):1286-92.
[8]Fan H, Yang L, Fu F, et al. Cardioprotective effects of salvianolic Acid a on myocardial ischemia-reperfusion injury in vivo and in vitro [J]. Evid Based Complement Alternat Med,2012,2012: 508938.
[9]Wang B, Liu JX, Meng HX, et al. Blocking effect of salvianolic acid a on calcium channels in isolated rat ventricular myocytes [J]. Chin J Integr Med,2012,18(5):366-70.
[10]Wang SB, Yang XY, Tian S, et al. Effect of salvianolic acid A on vascular reactivity of streptozotocin-induced diabetic rats [J]. Life Sci,2009,85(13-14):499-504.
[11]Du GH, Qiu Y, Zhang JT. Protective effect of salvianolic acid a on ischemia-reperfusion induced injury in isolated rat heart[J].Yao Xue Xue Bao,1995,30(10):731-735.
[12]Wang XJ, Wang ZB, Xu JX. Effect of salvianic acid A on lipid peroxidation and membrane permeability in mitochondria [J]. J Ethno pharmacol,2005,97(3):441-445.
[13]Wang SB, Tian S, Yang F, et al. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats [J]. Eur J Pharmacol,2009,15(1-3):125-132.
[14]Jiang B, Zhang L, Li M, et al. Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress [J]. Food Chem Toxicol,2008,46(5):1510-1515.
[15]Pan H, Li D, Fang F. et al. Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury [J]. J Cardiovase Pharmacol.2011.58(5):535-542.
[16]Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart:angels versus demons in a heart-breaking tale [J]. Physiol Rev,2010,90(4):1507-1546.
[17]Adamek A, Jung S, Dienesch C, et al. Role of 5-lipoxyge-nase in myocardial ischemia-reperfusion injury in mice [J]. Eur J Pharmacol,2007,571(1):51-54.
[18]Tao J, Zhu W, Li Y, et al. Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion [J]. Am J Physiol Heart Circ Physiol,2011,301(4):H1471-1486.
[19]Xu H, Yao Y, Su Z, et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-& alpha;/JNK[J]. Am J Physiol Heart Circ Physiol,2011, 300(3):H913-921.
[20]Zhai CL, Zhang MQ, Zhang Y, et al. Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway[J]. Acta Pharmacol Sin,2012, 33(12):1477-1487.
[21]Matsui T, Tao J, Monte F, et al. Role of apoptosis in cardiovascular disease[J]. Apoptosis,2009,14(5): 536-548.
[22]Hajjar, RJ. Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation,2001,104(7):330-335.
[23]Li C, Tian J, Li G, et al. Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways. Eur. J. Pharmacol,2010,649(6):100-107.
[24]Sun D, Huang J, Zhang Z, et-al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One,2012,7(6):334-341.
[25]Qi, L, Pan H, Li, D, et al. Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes. Eur. J. Pharmacol.2011,668(1-2):201-207.
[26]Ferrandi C, Ballerio R, Gaillard CR, et al. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in an aesthetized rats. Br J Pharmacol, 2004,142(6):953-960.
[27]Strohm C, Barancik T, Bruhl M.L, et al. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium[J]. J Cardiovasc Pharmacol,2000,36,218-229.
[28]Cheng, HY. Hsieh MT. Neuroprotective effect of luteolin on amyloid beta protein (25-35)-induced toxicity in cultured rat cortical neurons[J]. Phytother Res,2010,24(6):S102-S108.
[29]Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease[J]. Apoptosis,2009,14,536-548.
[30]Maenpaa CJ, Shames BD, Why SK, et al. Oxidant-mediated apoptosis in proximal tubular epithelial cells following ATP depletion and recovery. Free Radic Biol Med,2008,44,518-526.
[31]Nam YJ, Mani K, Ashton A, et al. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell 2004,15,901-912.
[32]Song J, Liu K, Yi J. Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium/mitochondrion/caspases-dependent pathway. Planta Med,2010,76,433-438.
[33]Negoro S, Kunisada K, Tone E, et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res.2000,47,797-805.
[34]Bohlooly YM, Olsson B, Bruder CE, et al. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes, 2011,54(1):51-62.
[35]Tsang MW, Davidoff R, Korach A, et al. Diastolic dysfunction after coronary artery bypass grafting the effect of glucose-insulin-potassium infusion.J Card Surg,2012,22(3):185-91.
[36]Boengler K, Hilfiker-Kleiner D, Drexler H, et al.The myocardial JAK/STAT pathway:From protection to failure. Pharmacol Ther,2008,120,172-185.
[37]Miura K, Fujibuchi W, Unno M. Splice variants in apoptotic pathway. Exp Oncol.2012,34(3):212-7.
[38]Murrry CE, Jenning RB, Reimar KA, et al. Preconditioning with ischemia:adelayoflethalcell injury in ischemic myocardium[J]. Circulation,1986,74(5):1124
[39]Saraste A, Arola A, Vuorinen T, et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol.2010,12(5):255-62.
[39]Wagner M, Siddiqui MA. Signaling networks regulating cardiac myocyte survival and death[J]. Curr Opin Investig Drugs,2009,10,928-937.
[40]Shirato K, Imaizumi K, Miyazawa K, et al. Apoptosis induction preceded by mitochondrial depolarization in multiple myeloma cell line U266 by 2-aminophenoxazine-3-one. Biol Pharm Bull,2011,31(1):62-7.
[41]Burley DS, Ferdinandy P, Baxter GF. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion:Opportunities and obstacles for survival signaling Br J Pharmacol,2007,152, 855-869.
[42]Han J, Kim N, Joo H, et al. ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol,2002,283, H1545-1554.
[43]Guanetal P, Linz W, Hubschle T, et al. Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies. J Transl Med,2013,11(1):84.
[44]Hu C, Chen J, Dandapat A, et al. LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J. Mol. Cell. Cardiol,2008,44(7):76-83.
[45]Kataoka K, Hasegawa K, Sawamura T, et al. LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun,2003,300(4):656-660.
[46]Lv L, Zhang Y, Kong Q. Luteolin prevents LPS-induced TNF-a expression in cardiac myocytes through inhibiting NF-κB signaling pathway. Inflammation,2011,34(5):620-629.
[47]Miura T, Liu Y, Goto M, et al. Mitochondrial ATP-sensitive K+ channels play a role in cardioprotection by Na+-H+ exchange inhibition against ischemia/reperfusion injury. J. Am. Coll. Cardiol,2001,37(7): 957-963.
[48]Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion [J]. Am Heart J,2000, 139(2n3):S115-S119.
[49]Bohlooly YM, Bollano E, Mobini R, et al. Selective cerebral. expression of growth hormone alters cardiacfunction, morphology, energy metabolism and catecholamines in trans genicmice[J]. Growth HomrIGF Res,2005,15(2):148-155.
[50]Apstein C. Increased glycolytie substrate protection improves ischemic cardiac dysfunction and reduces injury[J]. Am Heart J,2000,139(2Pt3):S107-S114.
[51]Nordlie MA, Wold LE, Simkhovich BZ, et al. Molecular aspects of Ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy[J]. J Cardio vase Pharmacol Ther,2006,11(1):17-30.
[52]Galang N, Sasaki H, Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy[J]. Toxicology,2000,148(2/3):111-118.
[53]Kim JK, Pedram A, Razandi M, et al. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinaseis[J]. J Biol Chem,2006,281(10): 6760-6767.
[54]Castedo E, Segovia J, Escudero C, et al. Ischemia-reperfusion injury duirng experimental heart transplantation:evlauation of trimetaz idinepscytoprotective effect [J]. Rev Esp Cordial,2005,58(8): 941-950.
[55]Claeysetal DM, Forgiarini LF, da Rosa DP. Endobronchial perfluorocarbon administration decreases lung injury in an experimental model of ischemia and reperfusion. J Surg Res,2013, doi:pii: S0022-4804(13)00061-9.10.1016/j.jss.2013.01.035.
[56]Maenpaa CJ, Shames BD, Vanwhy SK, et al. Oxidant mediated-apoptosis in proximla tubular epithelial cells following ATP depletion and recovery [J]. Free Radical Biol Med,2008,44(4):518-526.
[57]Feygin J, Hu Q, Swingen C, et al. Relationships between regional Myocardial wall stress and bioenergetics in heart with left ventricular hypertrophy [J]. Am J Physiol Hear Circ Physiol,2008,294 (5): 2313-2321.
[58]Kandzair DE. Double negatives[J]. Am Hean J,2003,145(1):9-11.
[59]Brunner F, Maier R, Andrew P, et al. Attenuation of myocardial ischemia/reperfusion in mice with myocyte speciifc overexpression of endothelial nitric oxidesynthase [J], Cardio vase Res,2003,57 (1): 55-62.
[60]Kwon KY, Cho CH, Kim SP, et al. Apoptosis induced by preservation and reperfusion in canine lung transplantation[J]. Transplant Proc,2003,35(1):134-137.
[61]Maulik N, Yoshida T, Engelman RM, et al. Ischemic preconditioning attenuates apoptotic cell death associated with isehemia/reperfusion[J]. Mol Cell Bio chem,1998,186(1/2):139-145.
[62]SarasteA. Apoptosis in humna acute myocardial infarction[J]. Circulation,1997,95(2):320-323.
[63]Shiirto K, Otani H, Yamamoto F, et al. MK2 2 gene knockout mouse hearts carry anti-apoptotic signal and resistant to ischemia reperfusion injury [J]. J Mol Cell Cardiaol,2005,38(1):93-97.
[64]Venardos KM, Zatta AJ, Marshall T, et al. Reduced L-arginine transport contributes to the pathogenesis of myocardial isehemia-repefusion injury [J]. J Cell Bio chem.,2009,108(1):156-168.
[65]Adamek A, Jung S, Dienesch C, et al. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice [J]. Eur J Pharmacol,2007,571(1):51-54.
[66]Xie JR, Yu LN. Cardioprotcetive effects of eyelosporine. A inaninvivo model for mycoardial ischemia and reperfusion[J]. Acta Anaesthesiol Scand,2007,51(7):909-913.
[67]韩景波,张以昆,方显明.论治冠心病的经验[J].国际中医中药杂志,2011,15(4)：156-158.
[68]陈相.浅谈心肌缺血再灌注损伤的中医病机及其防治[J].陕西中医,2008,29(6)：697-699.
[69]邓铁涛,康文英,沃兴德等.血府逐瘀汤对乳鼠心肌细胞缺血再灌注损伤的影响[J].中国药物与临床.2006,6(8)：590-592.
[70]赵文举,赵彩云.冠心病不稳定心绞痛病案再讨论：兼与张东等大夫商榷[J].中医杂志,1998,9：553-554.
[71]张文高,黄先勇.心肌心肌缺血预处理机理研究近况[J].中国急救医学,2002,22(3)：177.
[72]杨培君,高承贤,楼兰花等.杨培君治疗冠心病心绞痛经验[J].中医杂志,2004,10(7)：737-738.
[73]倪欢欢.林钟香治疗心血管病验案3则[J].江西中医药,2012,3：23-25.
[74]文小敏,袁晓清,贺运河.益气活血方对急性心肌梗死气虚血瘀型治疗作用的临床研究[J].南方医科大学学报,2008,1：149-150.
[75]杨大成,武宗义,侯彬等.心络胶囊在不稳定型心绞痛患者介入治疗中的作用[J].中国医药导报,2010,20:17-20.
[76]方居正.不活动时胸痛应防心绞痛[J].老年健康,2007,12(2)：110-113.
[77]方旭.心血管病经方论治[M].北京：人民卫生出版社,2007.
[78]孙文奇,杨关林.杨关林教授中西医结合治疗冠心病经验[J].吉林中医药杂志,2008,12：46-48.
[79]冯玲,曹洪欣,曹洪欣.益气升陷法治疗心血管疾病经验[J].中医杂志,2009,4：302-303
[80]王万军,胡焕柱,马长春.温阳化瘀法论治冠心病心绞痛30例[J].吉林中医药杂志,2007,5：21.
[81]刘欣,杨引,刘新.参附注射液预处理对大鼠心肌缺血再灌注损伤时心肌能量代谢的影响[J].中国中医急诊,2009,18(7)：1117-1118.
[82]沈映君.中药药理学[M].人民卫生出版社,2004年,3月.
[83]赵燕,件文,侯京武,等.钙超负荷和丹酮对线粒体过氧化的影响.生物化学与生物物理学报,1995,27(6)：610-615.
[84]石刚刚,尹俊,陈绍如,等.丹参和血液稀释对心肌缺血/再灌注损伤的保护作用.中国中西医结合杂志,1999,19(1)：40-42.
[85]藤木辛一.丹参酮关联化合物的研究.国外医学中医学分册,1991,13(4)：53-55.
[86]陈铎葆.红花提取物预处理对缺血再灌注心肌的影响[J].中医杂志,‘2006,47(2)：652-654.
[87]夏泉.当归的药理作用研究进展[J].时珍国医国药,2012,3(15)：1112-113.
[88]欧阳昌汉,吴基良,陈金和.黄芩苷对大鼠心肌缺血再灌注时细胞凋亡的影响[J].中药药理与临床.2011,22(2)：19-21.
[89]雷正一,王硕仁.黄芪对心血管系统的作用.中国中西医杂志,2003,13(7)：443.
[90]石刚刚,陈锦香,李长潮,等.黄芪注射液对冠状动脉直接作用的研究.中药新药与临床药理,2010,10(1)：38-39.
[91]陈健.黄芪注射液的药理作用及临床应用.天津医科大学学报,2005,11(1)：153-157
[92]周苏宁,马学盛,张文高.黄芪注射液防治心血管疾病的临床和基础研究.中国中西医结合急救杂志,2010,7(3)：124-125
[93]冯津萍,卢奕,赵炳让.黄芪抑制家兔心肌缺血/再灌注时细胞凋亡的实验研究.中国中西医结合急救杂志,2001,8(1)：13-15
[94]王丽娟.麦冬药理作用与临床应用研究进展[J].中华医学研究杂志,2009,5(9)：23-25.
[95]林巧.赤芍药理作用与临床应用的研究进展[J].中华医学研究杂志,2009,6(5)：34-36..
[96]赵惠,李益民.刺五加注射液对冠心病心绞痛的的LPO、SOD变化的影响.新中医,1996,62-65.
[97]Kerry NL, Abbey M.Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro [J] Atherosclerosis,1997,135(1):93-102.
[98]LekaNSs J, Rallidis LS, Anareadou I, et al. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart isease [J]. Eur J Cardiovasc Prev and Rehabil,2005,12(6): 596-600.
[99]赵文晓.白黎芦醇对冠脉结扎诱发大鼠急性心肌缺血的保护作用的研究.J HARBIN MEDICAL UNIVERSITY.2006,40(3):69.
[100]Dernek S, INSzler M, Erkasap N, et al. Cardioprotection with resveratrol pretreamtent:improved beneficial effects over standard treatment in rat hearts after global ischemia [J]. Scand Cardiovasc J,2004,38(4): 245-254.
[101]张志琳,吴鸿飞,包仕尧,等.血管内皮细胞缺氧性损伤及药物干预作用的实验观察.江西医药,2012,24(11)：805.
[102]林蓉,刘俊田,甘伟杰,等.川芎嗪对缺氧缺糖状态下培养的血管内皮细胞EVC-304的影响.中国中药杂志,2004,29(5)：462-464.
[103]朱陵群,赵明镜,王硕仁,等.血府逐瘀121服液对大鼠缺氧一再给氧损伤心脏微血管内皮细胞黏附分子表达的影响[J].中西医结合心脑血管病杂志,2011,4(8)：692-694.
[104]陈铎葆.红花提取物预处理对缺血再灌注心肌的影响[J].中医杂志,2006,47(2)：652-654.
[105]吴永涛,罗毅,顾云,等.参附注射液对大鼠心肌缺血再灌注损伤的保护作用[J].中国比较医学杂志,2011,17(1)：26-29.
[106]马晓鹂,张良清,邵义明,等.参附注射液对缺血再灌注损伤大鼠心肌细胞凋亡和NF-KB表达的影响[J].中国医师杂志,2011,9(6)：759-760.
[107]沈炳权,蔡兆斌,徐群红,等.葛根素对家兔心肌缺血再灌注损伤的保护作用[J].中国中西医结合急救杂志,2009,11(6)：361-363.
[108]吕宝经,荣烨之.生脉散对急性心肌梗塞患者的抗脂质过氧化作用.中国中西医结合杂志,2012,14(12)：712-715.
[109]何涛,张红星,高清元.生脉注射液在心脏直视手术中对心肌缺血/再灌注损伤的保护作用.临床医药实践杂志,2005,14(1)：28-29.
[110]张殿清,王漪绮,关承华,等.复方丹参与辅酶心肌线粒体Q10琥珀酸脱氢酶活性的影响.哈尔滨医科大学学报,1991,25(6)：413-414.
[111]苏晓华,梁殿权,王孝鸣,等.丹参素(DS-182)对心肌线粒体氧自由基损伤的保护作用.中国病理生理杂志,1992,8(2)：122-124.
[112]贾钰华,周玉平,孙学刚,等.定心方防治心肌缺血再灌注心律失常大鼠的心肌蛋白质组初步研究[J].辽宁中医杂志,21307,34(9)：1212--1214.
[113]吴伟康,侯灿,罗汉川等.四逆汤改善缺血心肌能量代谢的作用及机制探讨.中国病理生理杂志,1998,14(6)：634-636.
[114]吴健宇,李仪奎,符胜光,等.补阳还五汤药物血清对自由基损伤的血管内皮细胞的保护作用：中药药理与临床,2009,15(2)：3-5.
[115]储胜利,施学筠,席时芳,等.黄芪皂甙提高心脏保存效果的实验研究[J].中国中西医结合杂志,2011,19(8)：481-483.
[116]徐贵成,高荣林,吴以岭,等.通心络胶囊治疗冠心病心绞痛的临床研究[J].中国中西医结合杂志,2012,7(2)：231-233.
[117]张华,梁慕筠,马志雄,等.补阳还五汤治疗冠心病的临床研究及其作用机制探讨[J].中国中西医结合杂志,12005,15(4)：213-215.
[118]Morrison LE, Whittaker RJ, Klepper RE, et al. Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model [J]. Am J Physiol Heart Circ Physiol,2004,286(3):H847-855.
[119]Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts:focus on Akt and protein kinase C signaling [J]. J Pharmacol Exp Ther,2005,315(3): 1125-1135.
[120]Fang F, Li D, Pan H, et al. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion[J]. Pharmacology,2011,88(3-4): 149-158.
[121]Qarawani D, Cohen A, Nahir M, et al. Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan[J]. Int J Cardiol,2012, S0167-5273(12):1194-1121.
[122]Kapur A, Qureshi AC, Gallagher S, et al. Myocardial function may improve equally in diabetic patients following both multivessel percutaneous coronary intervention and coronary artery bypass grafting: results from a CARDia trial substudy [J]. Eur J Echocardiogr,2011,12(12):904-909.
[123]Arbel Y, Banai S. Response to the letter:How to manage coronary slow flow following PCI [J]. Int J Cardiol,2012,154(3):373.
[124]Mrdovic I, Savic L, Krljanac G, et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention:insight into the RISK-PCI trial [J]. Coron Artery Dis,2012,23(1):1-8.
[125]Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury:a neglected therapeutic target. J Clin Invest,2013,123(1):92-100.
[126]Lishmanov YB, Maslov LN. Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use [J]. Kardiologiia,2010,50(6):68-74
[127]陈丽娜,王化良.瓜蒌薤白半夏汤治疗胸痹研究进展[J].河南中医,2012,9：1254-1256.
[128]潘明政.以活血化瘀为主辨证论治消渴胸痹症[J].中国全科医学：医生读者版,2010,2：55-56.
[129]Baines CP. How and when do myocytes die during ischemia and reperfusion:the late phase [J]. J Cardiovasc Pharmacol Ther,2011,16(3-4):239-243.
[130]Xu J, Tian W, Ma X, et al. The molecular mechanism underlying morphine-induced Akt activation:roles of protein phosphatases and reactive oxygen species [J]. Cell Biochem Biophys,2011,61(2):303-311.
[131]Penna C, Alloatti G, Gallo MP, et al. Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart [J]. Cell Mol Neurobiol,2010,30(8):1171-1179.
[132]Geelen T, Paulis LE, Coolen BF, et al. Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury[J]. Contrast Media Mol Imaging,2013,8(2):117-126.
[133]Heusch G. Cardioprotection:chances and challenges of its translation to the clinic [J]. Lancet,2013, 381(9861):166-175.
[134]Ren JY, Song JX, Lu MY, et al. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats:Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P [J]. Regul Pept,2011,169(1-3):49-57.
[135]He H, Xu J, Xu Y, et al.Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats [J]. J Ethnopharmacol, 2012,140(1):73-82.
[136]Wu Q, Li H, Wu Y, et al. Protective effects of muscone on ischemia-reperfusion injury in cardiacmyocytes [J]. J Ethnopharmacol,2011,138(1):34-39.
[137]Zhou L, Zuo Z, Chow MS. Danshen:an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use [J]. J Clin Pharmacol,2005,45(12):1345-1359.
[138]Tao YY, Liu CH. Progress of research on mechanism of salvia miltiorrhiza and its chemical ingredients against liver fibrosis[J]. Zhong Xi Yi Jie He Xue Bao,2004,2(2):145-148.
[139]Zhang L, Zhang W, Zhao Y, et al. Research progress of salvianolic acid A [J]. Zhongguo Zhong Yao Za Zhi,2011,36(19):2603-2609.
[140]Li L. Protective effects of schisanhenol, salvianolic acid A and SY-L on oxidative stress induced injuries of cerebral cells and their mechanisms [J]. Sheng Li Ke Xue Jin Zhan,1998,29(1):35-38.
[141]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury [J]. Molecules,2011,16(12):10002-10012.
[142]Qin Y, Yu Y, Dong H, et al. MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis [J]. Int J Med Sci,2012,9(6): 413-423.
[143]Sun Q, Kang Z, Cai J, et al. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats [J]. Exp Biol Med,2009,234(10):1212-1219.
[144]Gomes OM, Magalhaes Mde M, Abrantes RD. Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts [J]. Rev Bras Cir Cardiovasc,2010,25(3): 388-392.
[145]Strasen J, Ritter O. Role of nNOS in cardiac ischemia-reperfusion injury[J]. Trends Cardiovasc Med, 2011,21(2):58-63.
[146]Vilahur G, Juan-Babot O, Pena E, et al. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction [J]. J Mol Cell Cardiol,2011,50(3):522-533.
[147]Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats[J]. PLoS One,2012,7(11):e48872.
[148]Janssen PM. Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere [J]. Am J Physiol Heart Circ Physiol,2010,299(4):H 1092-1099.
[149]Andersen JL, Kornbluth S. The tangled circuitry of metabolism and apoptosis[J]. Mol Cell,2013, 49(3):399-410.
[150]Bonneau B, Prudent J, Popgeorgiev N,et al. Non-apoptotic roles of Bcl-2 family:The calcium connection [J]. Biochim Biophys Acta,2013 Jan 27. doi:pii:S0167-4889(13) 00036-0.10.1016/ j.bbamcr.2013.01.021.
[151]Tsuruyama T, Okamoto S, Fujimoto Y, et al. Histology of intestinal allografts:lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis [J]. Am J Surg Pathol.2013,37(2):178-184.
[152]Distefano G, Sciacca P. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure[J]. Ital J Pediatr,2012,38(5):41.
[153]Yin XL, Shen H, Zhang W, et al.Inhibition of endoplasm reticulum stress by anisodamine protects against myocardial injury after cardiac arrest and resuscitation in rats [J]. Am J Chin Med,2011, 39(5):853-866.
[154]Tao Z, Zhao Z, Lee CC.5'-Adenosine monophosphate induced hypothermia reduces early stage myocardial ischemia/reperfusion injury in a mouse model [J]. Am J Transl Res,2011,3(4):351-361.
[155]Verma YK, Raghav PK, Raj HG, et al. Enhanced heterodimerization of Bax by Bcl-2 mutants improves irradiated cell survival [J]. Apoptosis,2013,18(2):212-225.
[156]Zhang L, Zhang S. Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells [J]. Phytother Res,2011,25(10):1551-1557.
[157]Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease [J]. Apoptosis,2009,14(4):536-48.
[158]Shaw J, Kirshenbaum LA. Molecular regulation of autophagy and apoptosis during ischemic and non-ischemic cardiomyopathy[J]. Autophagy,2008,4(4):427-434.
[159]Hu ZY, Liu J. Effects of emulsified isoflurane on haemodynamics and cardiomyocyte apoptosis in rats with myocardial ischaemia[J]. Clin Exp Pharmacol Physiol,2009,36(8):776-83.
[160]Bo CJ, Chen B, Jia RP, et al. Effects of ischemic preconditioning in the late phase on homing of endothelial progenitor cells in renal ischemia/reperfusion injury [J]. Transplant Proc,2013,45(2):511-6.
[161]Chablais F, Veit J, Rainer G, et al. The zebrafish heart regenerates after cryoinjury-induced myocardial infarction [J]. BMC Dev Biol,2011,11(4):21-25.
[162]Yu SJ, Yoon JH, Yang JI, et al. Enhancement of hexokinase Ⅱ inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition [J]. J Bioenerg Biomembr,2012,44(1):101-115.
[163]Kelly KJ, Kluve-Beckerman B, Zhang J, et al. Intravenous cell therapy for acute renal failure with serum amyloid A protein-reprogrammed cells [J]. Am J Physiol Renal Physiol,2010,299(2):F453-64.
[164]Wang X, Wang Y, Jiang M, et al. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways [J]. J Ethnopharmacol,2011, 135(3):662-671.
[165]Witzel F, Maddison L, Bluthgen N. How scaffolds shape MAPK signaling:what we know and opportunities for systems approaches [J]. Front Physiol,2012,3:475. doi:10.3389/fphys.2012.00475.
[166]Ismail NS, Pravda EA, Li D, et al. Angiopoietin-1 reduces H (2) O(2)-induced increases in reactive oxygen species and oxidative damage to skin cells [J]. Invest Dermatol,2010,130(5):1307-1317.
[167]Taj G, Agarwal P, Grant M, et al.MAPK machinery in plants:recognition and response to different stresses through multiple signal transduction pathways [J]. Plant Signal Behav,2010,5(11):1370-1378.
[168]Lin CL, Tseng HC, Chen RF, et al. Intracellular zinc release-activated ERK-dependent GSK-3β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury [J]. Cell Death Differ, 2011,18(10):1651-1663.
[169]Xu H, Yao Y, Su Z,et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-& alpha;/JNK [J].Am J Physiol Heart Circ Physiol, 2011,300(3):H913-921.
[170]Kurian MV, Hamilton L, Keeven J, et al. Enhanced cell survival and diminished apoptotic response to simulated ischemia-reperfusion in H9c2 cells by magnetic field preconditioning [J]. Apoptosis,2012, 17(11):1182-1196.
[171]Liu H, Pedram A, Kim JK.Oestrogen prevents cardiomyocyte apoptosis by suppressing p38a-mediated activation of p53 and by down-regulating p53 inhibition on p38β [J]. Cardiovasc Res,2011,89(1): 119-128.
[172]Hu X, Wang H, Liu J, et al. The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation [J]. Arch Dermatol Res,2013 Mar 15. [Epub ahead of print]
[173]Wiejak J, Dunlop J, Stoyle C,et al. The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun [J]. Cell Signal,2012,24(8):1690-1699.
[174]Wang X, Chen WR, Xing D. A pathway from JNK through decreased ERK and Akt activities for FOXO3 a nuclear translocation in response to UV irradiation [J]. J Cell Physiol,2012, 227(3):1168-1178.
[175]Ferrandi C, Ballerio R, Gaillard P, et al. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats [J]. Br J Pharmacol,2004,142(6):953-960.
[176]Ottani A, Giuliani D, Galantucci M,et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism [J]. Eur J Pharmacol,2010,637(1-3):124-130.
[177]Fey D, Croucher DR, Kolch W, et al. Crosstalk and signaling switches in mitogen-activated protein kinase cascades [J]. Front Physiol,2012,3:355. doi:10.3389/fphys.2012.00355.
[178]Masuda K, Katagiri C, Nomura M,et al. MKP-7, a JNK phosphatase, blocks ERK-dependent gene activation by anchoring phosphorylated ERK in the cytoplasm [J]. Biochem Biophys Res Commun, 2010,393(2):201-206.
[179]Krstic A, Kocic J, Ilic V, et al. Effects of IL-17 on erythroid progenitors growth:involvement of MAPKs and GATA transcription factors [J]. J Biol Regul Homeost Agents,2012,26(4):641-652.
[180]Bermudez O, Pages G, Gimond C. The dual-specificity MAP kinase phosphatases:critical roles in development and cancer [J]. Am J Physiol Cell Physiol.2010,299(2):C189-202.
[181]Keyse SM. Dual-specificity MAP kinase phosphatases (MKPs) and cancer[J]. Cancer Metastasis Rev. 2008,27(2):253-61.
[182]Wei X, Guo W, Wu S, et al. Oxidative stress in NSC-741909-induced apoptosis of cancer cells [J]. J Transl Med,2010,16,8:37.
[183]Katagiri C, Masuda K, Urano T, et al.Phosphorylation of Ser-446 determines stability of MKP-7[J]. J Biol Chem,2005,280(15):14716-14722.
[184]Paumelle R, Tulasne D, Leroy C,et al. Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells[J]. Mol Biol Cell,2000, 11(11):3751-3763.
[185]Monick MM, Powers LS, Gross TJ, et al. Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1[J]. J Immunol,2006,177(3):1636-45.
[186]Dickinson RJ, Keyse SM. Diverse physiological functions for dual-specificity MAP kinase phosphatases[J]. J Cell Sci,2006,119(Pt 22):4607-4615.
[187]Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival[J].FASEB J,2008,22(4):954-965.
[1]Blebea J, Kerr JC, Padberg FT, et al. Triphenyl tetrazolium chloride as a histochemical marker of skeletal muscle ischemia and reperfusion injury[J]. Curr surg,1987,44(2): 134-136
[2]Murry CE, Jennings RB. Reimer KA, et al. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardiumr[J]. Circulation,1986,74(5):11124-1136.
[3]Yoshitomi O, Cho S, Hara T, et al. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs.Shock,2012,38(1):92-97.
[4]Asdaq SM, Inamdar MN, Asad M. Pharmacodynamic interaction of garlic with propranolol in ischemia-reperfusion induced myocardial damage. Pak J Pharm Sci,2010,23(1):42-47.
[5]Li MP, Sun GJ, You XH. Effects of electroacu puncture stimulation of scalp-point on cardiac sympathetic discharges, myocardial betal-adrenoceptor protein expression and plasma norepinephrine concentration in myocardial ischemia-reperfusion injury rats. Zhen Ci Yan Jiu,2012,37(5):385-389.
[6]Wu WY, Wang YP. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol Sin,2012, 33(9):1119-1130.
[7]Pan H, Li D, Fang F, et al. Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. J Cardiovasc Pharmacol,2011, 58(5):535-542.
[8]Yue QX, Xie FB, Song XY, et al. Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury. J Ethnopharmacol,2012,141(2):659-667.
[9]Tang Y, Wang M, Chen C,et al. Cardiovascular protection with danshensu in spontaneously hypertensive rats. Biol Pharm Bull,2011,34(10):1596-1601.
[10]Han B, Zhang X, Zhang Q, et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis,2011, 104(5):313-324.
[11]Obal D, Dai S, Keith R, et al. Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Res Cardiol,2012,107(6):305.
[12]Bhandary B, Piao CS. Kim DS, et al. The protective effect of rutin against ischemia/reperfusion-associated hemodynamic alteration through antioxidant activity. Arch Pharm Res,2012.35(6):1091-1097.
[13]Sun WH, Liu F, Chen Y. et al. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem Biophys Res Commun,2012,421(2):164-169.
[14]Huang C, Li R, Zeng Q, et al. Effect of minocycline postconditioning and ischemic postconditioning on myocardial ischemia-reperfusion injury in atherosclerosis rabbits. J Hua zhong Univ Sci Technolog Med Sci,2012,32(4):524-529.
[15]徐正褂,王万铁,李东.川芎嗪对家兔心肌IRI的保护作用[J].基础医学与临床,1997,17(4)：68-71.
[16]Chen G, Fu Y, Wu X. Protective effect of Salvia miltiorrhiza extract against renal ischemia-reperfusion-induced injury in rats. Molecules,2012,17(2):1191-1202.
[17]Tang Y, Wang M, Le X, et al. Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats. Phytomedicine,2011, 18(12):1024-1030.
[18]Wang L, Lv D, Liang R, et al. Protection on myocardial ischemia and reperfusion injury by Salvia miltiorrhiza hairy root in isolated Langendorff rat hearts. Zhongguo Zhong Yao Za Zhi,2009,34(14):1848-1851.
[19]昊志,夏正远,黄海波等.复方丹参对心内直视手术心肌缺血再灌注后血清过氧化脂质及前列环素变化的影响[J].临床麻醉学杂志,2008,18(5)：242-244.
[20]Wu L, Qiao H, Li Y, et al. Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats. Phytomedicine,2007,14(10):652-658.
[21]Hu X, Xu C, Zhou X, et al.Sodium butyrate protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Biomed Pharmacother,2010,25(6):578-583.
[22]Fu J, Huang H, Liu J, et al. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol,2007,568(1-3):213-221.
[23]辛双生,王志宏,用俊英等.丹参液内关穴注射对心肌缺血性损伤大鼠心肌SOD、MDA含量与红细胞膜流动性关系的研究[J].中医研究,1999,12(2)：13-14.
[24]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules,2011,16(12):10002-12.
[25]Wang L, Lv D, Liang R, et al.Protection on myocardial ischemia and reperfusion injury by Salvia miltiorrhiza hairy root in isolated Langendorff rat hearts. Zhongguo Zhong Yao Za Zhi,2009,34(14):1848-1851.
[26]王泽君,鲍光宏.氧自由基引起心肌损伤的离子通道机制.高血压杂志,1998,1-4：237-240.
[27]Tanonaka K, Motegi K, Arino T, et al. Possible pathway of Na(+) flux into mitochondria in ischemic heart. Biol Pharm Bull,2012,35(10):1661-1668.
[28]Shintani-Ishida K, Inui M, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2□ overload. J Mol Cell Cardiol,2012,53(2):233-239.
[29]Jin C, Wu J, Watanabe M, et al. Mitochondrial K+ channels are involved in ischemic postconditioning in rat hearts. J Physiol Sci,2012,62(4):325-332.
[30].Chong ZZ, Xu QP, Sun JN. Effects and mechanisms of tri-acetylshikimic acid on platelet adhesion to neutrophils induced by thrombin and reperfusion after focal cerebral ischemis in rats[J]. Acta Pharmacol Sin,2001,22(8):679-684.
[31]Ialkel S, Ilekel H, Guger G, et al. Alterations in superoxide dismutase, glutathione penoxidase and catalase activities in experimental cerebral ischemia-reperfusion[J]. Res Exp Med,1999,199(3):167-176.
[32]Chiu PY, Wong SM, Leung HY, et al. Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKC□/mK (ATP) pathway in rats[J]. Phytomedicine,2011,18(11):916-925.
[33]Chiu PY, Wong SM, Leung HY, et al. Long-term treatment with danshen-gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive protein kinase C-ε/mK (ATP) pathway in rats[J]. Rejuvenation Res,2011,14(2):173-184.
[34]Beiral HJ, Rodrigues-Ferreira C, Fernandes AM, et al. The Impact of Stem Cells on Electron Fluxes, Proton Translocation and ATP Synthesis in Kidney Mitochondria after Ischemia/Reperfusion[J]. Cell Transplant,2012,23(4):123-126.
[35]Chiu PY, Wong SM, Leung HY, et al. Long-term treatment with danshen-gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive protein kinase C-ε/mK (ATP) pathway in rats[J]. Rejuvenation Res,2011,14(2):173-184.
[36]张桦,焦选茂,王孝铭等.缺血再灌注对大鼠心肌线粒体电子传递与质子泵出偶联的影响[J].中国病理生理杂志,1993,9(5)：561.
[37]Zhang WH, Wang JS, Zhou Y, et al. Gadolinium chloride and salvia miltiorrhiza compound ameliorate reperfusion injury in hepatocellular mitochondria[J]. World J Gastroenterol, 2003,9(9):2040-2044.
[38]胡敏霞,周密妹,胡先敏等.丹参酮对脑缺血再灌注大鼠脑损伤的保护作用及对能量代谢的影响[J].中国临床药学杂志,2006,15(3)：176-179.
[39]Chiu PY, Wong SM, Leung HY, et al. Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKC/mK (ATP) pathway in rats[J]. Phytomedicine,2011,18(11):916-925.
[40]De FI, Fernandez SM, Essenfeld SE, et al. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL in sepsis [J]. Chest,2004,125(6):1980-1982.
[41]Papathanassoglou ED, Moynihan JA, Ackerman M H. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patient? A review and a theoretical framework [J]. Crit Care Med,2010,28(2):537-549.
[42]Xie Z, Koyama T,Suzuki J, et al. Coronary reperfusion following ischemia:different expression of bcl2 and bax proteins and cardiomyocyte apoptosisr[J]. Jpn Heart J,2007.42: 759-770.
[43]Peng W, Liu Y, Xu WJ, et al. Role of beclin 1-dependent autophagy in cardioprotection of ischemic preconditioning[J]. J Huazhong Univ Sci Technolog Med Sci,2013,33(1):51-56.
[44]Shen M, Wu RX, Zhao L, et al. Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism[J]. PLoS One,2012,7(12):e51223.
[45]Dong L, Fan Y, Shao X, et al. Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis[J]. Food Chem Toxicol,2011,49(12):3211-3216.
[46]Yamamura T, Otani H, Nakao Y, et al. IGF21 differentailly regulates Bcl2 X1 and Bax and confers myocardial protection in the rat heartr[J]. Physiol Heart Circ Physiol,2011,280(4):1-12.
[47]Starczynski J, Pepper C, Pratt G, et al. The P2X7 receptor gene polymorphism has no effect on clinical prognostric markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytie leukaemia [J]. Br J Haenatol,2003, 123(1):66-71.
[48]张代富,阮长武,刘中民等.丹参对大鼠急性心肌缺血再灌注时心肌细胞凋亡及凋亡相关基因表达的影响[J].上海医学,2003,26(9)：1669-1670.
[49]Hin SW, Park JW, Suh MH, et al. Persistent expression of Fas/FasL mRNA in the mouse hippocampus after a single NMDA injection [J]. Neurochem,2008,71(6):1773-1776.
[50]Jiang CM, Han LP, Li HZ, et al. Calcium-sensing receptors induce apoptosis in cultured neonatal rat ventricular cardiomyocytes during simulated ischemia/reperfusion [J]. Cell Biol Int,2008,32(7):792-800.
[51]Lee P, Sata M, Lefer DJ, et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia reperfusion in vivor [J]. Am J Physiol Heart C/re Physiol,2003, 284(2):H456-H463.
[52]Pan H, Li D, Fang F, et al. Salvianolic acid a demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury [J]. J Cardiovasc Pharmacol, 2011,58(5):535-542.
[53]Yin Y, Guan Y, Duan J, et al. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusioninjury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol,2013,699(1-3):219-26.
[54]Fan H, Yang L, Fu F, et al. Cardioprotective effects of salvianolic Acid a on myocardial ischemia-reperfusioninjury in vivo and in vitro. Evid Based Complement Alternat Med,2012,2012:508938. doi:10.1155/2012/508938. Epub 2011 Jun 25.
[55]Yang LM, Xiao YL, Ou Yang JH. Inhibition of magnesium lithospermate B on the c-Jun N-terminal kinase 3 mRNA expression in cardiomyocytes encountered ischemia/reperfusion injury. Yao Xue Xue Bao,2003,38(7):487-491.
[56]HICKEY MJ, Hu RLEY JV, MORRISON WA. temporal and spatial relationship between no-flew phenomenon and postischemic necrosis in skeletal muscle. Am J Physio1.1996, 271(2):1277-1286.
[57]Gao F, Sun G, Ren X, et al. Protective effect of salvianolic acid B on isolated heart ischemia/reperfusion injury in rats. Zhongguo Zhong Yao Za Zhi,2012,37(3):358-361.
[58]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules,2011,16(12): 10002-10012.
[59]王保和,傅伟,李竹庭.丹酚酸B对急性心肌缺血再灌注损伤大鼠心肌保护作用的机制研究[J].天津中医学院学报,2004,23(3)：132-133.
[60]胡利民,张艳军,王威等.冰片与丹酚酸B和三七总皂苷配伍对局灶性脑缺血再灌注大鼠脑VEGF mRNA表达的影响[J].中国中西医结合急救杂志,2005,12(5)：263-266.
[61]李祖纯,夏祯芸.丹参酮ⅡA磺酸钠注射液对急性心肌梗死再灌注治疗后左心功能的影响[J].2006,24(3)：87-89.
[62]Han B, Zhang X, Zhang Q, et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis,2011, 104(5):313-24.
[63]Koeppen M, Harter PN, Bonney S, et al. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology,2012,116(6):1245-1257.
[64]Thomas CJ, Ng DC, Patsikatheodorou N, et al.Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK. Eur J Pharmacol,2011, 658(2-3):160-167.
[65]Zhao LJ, Men XL, Kong XY, et al. Preventive effects of salvia miltiorrhiza on multiple organ edema in the rats of limb ischemia/reperfusion Zhongguo Ying Yong Sheng Li Xue Za Zhi.2012,28(3):281-283.
[66]Jin YC, Kim CW. Kim YM. et al. Cryptotanshinone. a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur J Pharmacol,2009, 614(1-3):91-97.
[67]Han X, Liu JX, Ma XB, et al. Effects of shuang shen tong guan (SSTG) on TNF-alpha, ICAM-1 during myocardial ischemia-reperfusion injury. Zhong guo Zhong Yao Za Zhi, 2004,29(11):1073-1075.
[68]Jiang KY, Kung CG, Gu ZC. Effects of tanshinone-A sulfonate on adhesion molecule expression of endothelial cells and platelets in vitro[J]. Acta Phamacologica Sinica,1998, 19(1):47-50.
[69]Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.Pharmacol Ther.2008,117(2):280-295.
[70]Oh KS, Oh BK, Mun J, et al. Salvianolic acid A suppress lipopolysaccharide-induced NF-κB signaling pathway by targeting IKKβ[J]. Int Immunopharmacol,2011, 11(11):1901-1906.
[71]Shintani-Ishida K, Inui M, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2+ overload[J]. J Mol Cell Cardiol,2012,53(2):233-239.
[72]He Z, Peng Z, Jin L, et al. Effect of morphine preconditioning on mitochondrial permeability transition pore after myocardial ischemia-reperfusion injury in rats [J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2010,35(8):800-806.
[73]Inui M, Shintani-Ishida K, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2+ overload[J]. J Mol Cell Cardiol,2011,23(3):245-249.
[74]Yu W, Wang JJ, Wen ZY, et al. Influences and mechanism of verapamil on ischemia/reperfusion injury in cardiomyocytes of streptozotocin-induced diabetes mellitus rats[J]. Zhonghua Yi Xue Za Zhi,2010,90(42):3003-3007.
[75]Barba I, Chavarria L, Ruiz-Meana M, et al. Effect of intracellular lipid droplets on cytosolic Ca2+ and cell death during ischaemia-reperfusion injury in cardiomyocytes[J]. J Physiol, 2009,587(Pt 6):1331-1341.
[76]Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury [J]. Molecules,2011, 16(12):10002-10012.
[77]李玉梅,陈旭华.丹参对缺血心肌细胞L型钙电流的影响[J].安徽中医学院学报,2003,22(4)：29-32
[78]Dejonckheere E, Vandenbroucke RE, Libert C. Matrix metalloproteinases as drug targets in ischemia/reperfusion injury[J].Drug Discov Today,2011,16(17-18):762-778.
[79]高秀梅,张伯礼,商洪才等.复方丹参对缺血预适应大鼠心肌蛋白激酶C表达的影响.中 草药[J],2003,34(10)：933-935.
[80]Hu F, Koon CM, Chan JY, et al. The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury [J]. BMC Complement Altern Med,2012,12:249. doi:10.1186/1472-6882-12-249.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |